The effect of helical carbon nanotubes on macrophage function by Walling, Brent
  
THE EFFECT OF HELICAL CARBON NANOTUBES ON MACROPHAGE FUNCTION 
 
 
 
 
 
 
 
BY 
 
BRENT EDMOND WALLING 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in VMS – Veterinary Pathobiology  
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2013 
 
 
 
 
 
Urbana, Illinois 
 
 
 
Doctoral Committee: 
 
Associate Professor Gee Lau, Chair, Director of Research  
Professor Matthew Wallig 
Professor Federico Zuckermann  
Professor Steven Blanke  
ii 
 
ABSTRACT 
Occupational and environmental pulmonary exposure to carbon nanotubes 
(CNT) is considered to be a health risk with a very low threshold of tolerance as 
determined by the Center for Disease Control. Cell lines exposed to CNTs show a 
diverse range of adverse effects including reduced viability, impaired proliferation, and 
elevated reactive oxygen species generation. Additionally, CNTs inhibit internalization of 
targets in multiple phagocytic cell lines. Mice and rats exposed to CNTs often develop 
pulmonary granulomas and fibrosis. Furthermore, CNTs in mouse models have 
immunomodulatory effects. CNTs themselves are proinflammatory and can exacerbate 
the allergic response. However, CNTs may also be immunosuppressive, both locally 
and systemically. Studies examining the relationship of airborne particulate exposure 
prior to pulmonary infection have reached different conclusions. In some cases, pre-
exposure either had no effect or enhanced clearance of pathogens while other studies 
showed particulates inhibit clearance. Interestingly, most studies exploring this 
relationship use bacterial organisms which are not considered primary pulmonary 
pathogens. Additionally, harmony across studies, including those using pathogens, is 
problematic as different types of CNTs have shown dissimilar biological effects. For our 
studies we used the primary pulmonary pathogen Pseudomonas aeruginosa as our 
model pathogen to study how helical multi-walled carbon nanotubes (HCNTs) affected 
internalization and clearance of P. aeruginosa in mice models. The results showed that, 
although HCNTs can inhibit internalization through multiple processes, clearance of 
infection was not altered, which was attributed to an enhanced inflammatory response 
resulting from pre-exposure to HCNTs.  
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In addition, we have shown that the inhibition of P. aeruginosa internalization is 
directly related to the HCNT accumulation within macrophages and inhibition of 
internalization achieves significance at an intracellular accumulation >40%. To further 
explore how HCNTs may inhibit select components of the phagocytic response, we 
examined how HCNT exposure affected F-actin distribution. We have shown that HCNT 
exposure will result in disruption of normal F-actin structures in both RAW 264.7 
macrophages and harvested alveolar macrophages in a concentration dependent 
manner. 
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IL-17   Interleukin-17 
IP  Intraperitoneal 
KC  Keratinocyte chemoattractant 
LDH  Lactate dehydrogenase 
LPS  Lipopolysaccharide 
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MARCO Macrophage receptor with collagenous structure 
MCP-1 Monocyte chemoattractant protein-1 
MIP-1α Macrophage inflammatory protein-1 alpha 
MTS  3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium 
MTT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
MWCNT Multi-walled carbon nanotube 
MØ  Macrophage 
NF-κB  Nuclear factor kappa-light-chain-enhancer of activated B cells 
NO  Nitric oxide 
PBS  Phosphate buffered saline 
PMN  Polymorphonuclear cells 
SDS  Sodium dodecyl sulfate 
SEM  Scanning electron microscopy 
SR  Scavenger receptor 
SR-AI/II Scavenger receptor-A I/II 
SSA  Specific surface area  
SWCNT  Single walled carbon nanotube 
TiO2  Titanium dioxide 
TGF-β Transforming growth factor-beta 
TLR  Toll-like receptor 
TNF-α  Tumor necrosis factor-alpha 
XPS  X-ray photoelectron spectroscopy
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CHAPTER 1: GENERAL INTRODUCTION 
 
I. PULMONARY PARTICULATE TOXICOLOGY 
 
Concern regarding the presence of airborne particulates and the risk of 
developing pulmonary disease resulting from their inhalation has an extensive history. 
The first insights into the relationship between dust and pulmonary disease were made 
by Georgius Agricola and Paracelsus in the 15th and 16th century, although neither 
established a direct link [1]. It was in 1700 when Bernardino Ramazzini, who has been 
described as the father of occupational medicine, suggested that pulmonary disease 
may have an environmental basis and, after much research, recommended that dusty 
spaces should have good ventilation and that workers should remove themselves from 
their place of employment after the initial signs of lung disease [1,2].  However, changes 
in the work environment were not significantly implemented until the 20th century. By 
that time, three particulates had been identified as the cause of most diseases 
associated with particulate pulmonary toxicity: Quartz and the associated pulmonary 
condition silicosis, asbestos and pulmonary fibrosis and mesotheliomas, and the coal 
associated condition identified as pneumoconiosis [3]. A greater understanding of 
cellular toxicology and the development of innovative techniques followed as the field of 
particulate toxicology expanded and subsequently controls were implemented in 
regards to the aforementioned particulates. A second wave of particulates described as 
synthetic vitreous fibers arrived in the 1980s and, following multiple studies, a greater 
understanding of the mechanisms underlying the development of mesotheliomas and 
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the association with biopersistent fibers was made. Furthermore, an association 
between ultrafine particle (particles < 1 micron in diameter) exposure and pulmonary 
disease has been recently established [4] including exposure to air pollution [5,6] . 
With the acknowledgement of health risks associated with ultrafine particle 
exposure and establishment of control measures, the focus recently has shifted to 
aerosolized nanoparticles, a term used to describe intentionally or unintentionally 
manufactured ultrafine particles. The development of advanced technologies allowed 
engineering of sub-micron sized materials and led to the rapid development of man-
made nanoparticles, which are most commonly composed of silicon, carbon, or metal 
oxides [7,8]. The discovery of MWCNTs was initially described in 1991 [9] with 
synthesis comprised of wrapping a sheet of graphite into a multi-layered stable tube 
(Figure 1). Two years later, improved methods allowed for the rolling of graphite sheets 
into single layers using a metal catalyst, resulting in the production of SWCNTs [10,11]. 
Additional methods of synthesis, using pulsed laser vaporization or chemical-vapor 
deposition, were subsequently applied, which improved both the purity and the yield of 
nanotubes. Subsequently, novel carbon nanomaterials have also been synthesized 
including carbon nanohorns, nanocapsules, and helical multi-walled nanotubes from 
sheets of graphite. Carbon nanotubes had many physical characteristics that could be 
harnessed for commercial use. They possessed a tensile strength of up to 63 
gigapascals (in comparison steel typically has a tensile strength of 1.2 gigapascals) 
[12], could efficiently conduct heat and, depending on how they were synthesized, could 
be semi-conductive or non-conductive. Identification of different methods for synthesis 
of carbon nanotubes and improvements in technology during the 1990’s resulted 
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improved purity, uniformity, and lengths of the tubes while improved production 
techniques, intense research, and the development of production standards for carbon 
nanotubes led to the rapid expansion and production of CNTs in bulk [13]. 
Manufacturers have incorporated CNTs into many commercial products including metal 
and plastic composites, supercapacitors, and batteries with potential applications 
extending into the medical field including drug delivery, biosensors, and biomedical 
imaging. However, the properties which make carbon nanotubes an ideal material for 
use in commercial products, in particular their similarity to the size and shape of 
asbestos fibers, also raised the concerns of toxicologists.  
 
II. PULMONARY DEFENSE AGAINST INHALED PARTICULATES 
 
Deposition and clearance of inhaled airborne particulates is determined by three 
factors: respiratory tract anatomy, air flow patterns, and the aerodynamic characteristics 
of the individual particles (Figure 2) [3,14]. Physical characteristics of individual particles 
affect how they travel in the respiratory system and how they interact with the host once 
they are deposited. Among the different characteristics of airborne particles, size is 
considered to be most important. The physiology of the pulmonary system provides 
robust protection from the inhalation of airborne particulates, predominantly particulates 
> 1 micron in diameter. The nose is the primary filter for large airborne particulates and 
particles inhaled through the nares encounter warm, humidified air, which builds up on 
particles, adding to their overall mass. The architecture of the sinuses provides turbulent 
airflow from sudden directional changes or bifurcations, which leads to particles 
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impacting onto the epithelial surface, particularly at branches of the airways. Particles > 
5 microns are usually trapped by this mechanism in the nasopharyngeal region. The 
particles become embedded onto the mucous surface and are removed via mucocilliary 
transport to the oropharynx [15]. Additionally, nasal mucous contains enzymes, 
lysozymes, antibodies, phagocytic cells, and cytochrome P-450 dependent 
monooxygenases which can neutralize and help remove particles [14,16]. If these large 
particles are inhaled through the mouth, they also experience turbulent conditions at the 
bifurcations of the bronchi and bronchioles which lead to particles impacting onto the 
bronchiolar walls and removal by mucocilliary clearance. Smaller particles (1-5 
microns), which bypass entrapment in the nares, are usually captured in the 
tracheobronchial tree primarily by sedimentation. These particles become entrapped in 
the overlying mucous and, similar to the nares, are exposed to a host of protective 
molecules and are removed by the mucocilliary apparatus.  
Ultrafine particles and nanoparticles (less than 1 micron in diameter) bypass 
these mechanical defenses and can enter the alveolar spaces. Because of very low 
airflow, particles diffuse throughout the alveoli, allowing for deposition in the deep 
airways. The alveoli lack a mucocilliary clearance mechanism and removal of particles 
relies heavily on phagocytosis by pulmonary macrophages. However, internalization of 
particles < 100 microns in diameter by macrophages appears to be less effective than 
internalization of larger particles [17,18]. Nanoparticles will then tend to persist in the 
alveolar spaces,  
Unphagocytized particles will also impact on the alveolar epithelium by diffusion. 
From here, clearance may be accomplished by translocation to the blood stream. 
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However, translocation of nanoparticles across the epithelium is most efficient with 
soluble nanoparticle, whereas only a small fraction of insoluble nanoparticles penetrate 
the alveolar-blood barrier [19]. Additionally, monocytes and macrophages which have 
been exposed to larger particles, including aggregates of nanoparticles, show limited 
phagocytosis of small, individual particles [20,21]. Therefore, those nanoparticles, 
composed of carbon or other metals, which have not been functionalized (addition of 
molecules on the surface to improve solubility), most likely persist in the alveolar spaces 
and can serve as a constant source of irritation or injury. 
The inhalation of nanoparticles can induce a variety of adverse effects, locally 
and systemically, both as a result of inherent particle toxicity and the host immune 
response to the presence of particles per se. These effects can manifest both 
immediately after exposure as well as over time because of failure to clear the particles 
from the lungs. Particle toxicity is determined both by the characteristics of the particle, 
including size, surface area, surface modifications, and solubility, exposure time and 
concentration as well as host immunity [3]. The small size of nanoparticles permits 
insertion and crossing of individual cell membranes, which can result in cell injury or 
impaired function. The increased surface area of nanoparticles relative to larger 
particles of the same mass allows for increased surface interactions with biological 
systems and has been shown to result in a greater inflammatory response [21,22]. For 
example, reducing the size of particles increases the reactivity of TiO2 nanoparticles in 
biological systems [23]. This effect has been attributed to the generation of reactive 
oxygen species and subsequent oxidative stress [22]. Oxidative stress leads to 
increased intracellular Ca2+, activation of NF-κB, and production of proinflammatory 
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cytokines [24]. Insoluble nanoparticles may potentially reside in the pulmonary system 
for years which could result in many long-term health issues, including chronic 
inflammation and carcinogenesis [25]. 
 
III. CARBON NANOTUBE TOXICITY 
 
Carbon nanotubes typically have a very small diameter, with some SWCNTs 
having a diameter of ~ 1 nanometer and MWCNTs typically ranging from 25 to 200 
nanometers in diameter. Individual lengths of nanotubes can vary due to the methods, 
carbon sources, and processing conditions but can range from less than a micrometer 
to a few centimeters in length. Their carbon structure makes them relatively inert and 
hydrophobic. Individual SWCNTs can aggregate into small bundles or ropes due to Van 
Der Wall’s forces, which results in aerosolized or diluted SWCNTs existing as both 
individual tubes and small aggregates. Dispersing SWCNTs in surfactants or the 
addition of hydrophilic functional groups to the outer surface of SWCNTs reduces their 
tendency to clump. MWCNTs more often exist as single tubes due to weaker van der 
Waals forces but still can aggregate.  
The length/width ratio of CNTs, which make them ideal for mechanical, 
electronic, and biomedical applications, also raises concern regarding their 
biocompatibility. They are very similar to asbestos fibers, which are implicated in 
oxidative stress, lung injury, and mesothelioma development in the lungs [26]. The risk 
for occupational exposure to CNTs has increased as mass production has escalated. In 
addition, exposure to low ambient air concentrations of MWCNTs have been reported 
secondary to gas combustion emissions [27]. Cytotoxic evaluation of CNTs has focused 
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largely on alveolar epithelial cells, keratinocytes, and macrophages, since exposure is 
most likely through the skin or by inhalation. Based on published studies, carbon 
nanotube toxicity depends on multiple factors including the purity of the nanotubes, 
dispersion methods, addition of functional groups, and cells used. 
CNT toxicity towards macrophage cell lines appears to vary. SWCNTs showed 
no toxicity towards harvested mouse peritoneal macrophages [28,29] but were cytotoxic 
towards guinea pig alveolar macrophages [30]. Disparate results also appear in studies 
using immortalized cell lines. While one study demonstrated functionalized SWCNT 
toxicity towards J774 macrophages [31] others have shown no cytotoxic effects to J774 
macrophages [32] or RAW 264.7 macrophages [33-35]. Likewise, some studies showed 
that MWCNTs either decreased viability of RAW 264.7 macrophages [36] and J774 
macrophages [31] or showed no evidence of cytotoxicity [34,35].  
One reason for this has been attributed to using the MTT assay, a common cell 
viability assay, which has demonstrated CNT-mediated cellular cytotoxicity. 
Experiments have shown that some cytotoxicity dyes interact with CNTs including MTT, 
neutral red, and alamar blue [37-39], thus altering the data and producing a false 
positive toxic effect. This has been confirmed in vitro where the MTT assay has 
demonstrated CNT-mediated cytotoxicity while other assays showed no effect on cell 
viability [40,41]. 
Animal models of pulmonary exposure to CNTs have demonstrated the 
development of multiple lesions. Inhalation or aspiration of both SWCNTs and MWCNTs 
resulted in granulomas and pulmonary fibrosis in both mice and rats [42-46]. The effects 
were observed to be dose-dependent and occurred after only one administration. CNT-
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associated granulomas have been identified as far out as 60-90 days post-exposure 
[43,47]. The presence of granulomas was partially dependent on dispersal of the CNTs 
[48]. CNTs also reached the subpleural space [49]  and could be found penetrating the 
pleura 56 days after administration [50]. Goblet cell hyperplasia in the bronchioles 
following CNT exposure has also been reported [51,52].  
Analysis of lactate dehydrogenase and protein levels in the BALF, indicators of 
pulmonary toxicity, has shown that CNT administration can elevate both LDH and 
protein in the lungs of mice both in acute and chronic exposure models [53]. 
Additionally, instillation of CNTs will elicit a proinflammatory response. A single dose 
has resulted in a transient elevation of neutrophils in the BALF with either no change or 
a decrease in macrophages [54,55]. CNT exposure also has elevated multiple 
proinflammatory mediators and chemotactic factors in the BALF from animal models 
including KC, MCP-1, TNF-α, and IL-6 [54,56,57]. 
 
IV. AIRBORN PARTICULATES AND RESPIRATORY INFECTIONS 
 
The lung is a frequent target for pathogens and an infection results in a robust 
inflammatory response designed to neutralize and clear the pathogen and restore 
normal function to the lungs. Numerous epidemiologic studies have demonstrated a 
strong association between particulate matter exposure, including exposure to indoor 
pollutants, and risk for respiratory infections [58-60]. Exposure to carbon black and 
ambient particles has augmented respiratory syncytial infection in mice [61] and 
decreased clearance of Streptococcus pneumoniae [62]. Mice exposed to diesel 
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exhaust particles also show impaired clearance of Listeria monocytogenes [63]. 
Inhibition of the immune response to respiratory pathogens following exposure to 
airborne particles has been attributed, in part, to impaired phagocytic function of 
macrophages [62,64]. Additionally, it has been suggested that exposure to diesel 
exhaust potentiates the Th2 immune response while inhibiting the Th1 response which, 
in turn, inhibits cell-mediated immunity to respiratory infections [65]. 
Exposure to nanoparticles also can modulate the immune response in animal 
models. Systemic immune suppression has been reported in mice following exposure to 
MWCNTs [66-68] as well as asbestos and other environmental pollutants [69]. One 
study proposed that TGF-β release from CNT exposed lungs activated the 
cyclooxygenase pathways in the spleen, with subsequent decrease in the T-cell-
dependent antibody response, although the observed pulmonary inflammation was 
unremarkable [67]. A second study attributed decreased T-cell proliferation to the 
dysfunction of dendritic cells following exposure to SWCNTs [68]. On the other hand, 
both SWCNTs and MWCNTs have been shown to exacerbate pulmonary allergic 
inflammation [52,70].  
Prior or concurrent exposure to airborne nanoparticles that can modulate the 
immune system might also impair the response to infectious agents, but current data 
are unclear. Rats exposed to silica showed enhanced clearance of subsequent L. 
monocytogenes infection [71] while exposure to TiO2 rods, with a similar size to CNTs, 
did not affect clearance [72]. Exposure to SWCNTs has inhibited clearance of L. 
monocytogenes [57,63]. However, SWCNT exposure had no effect on the early immune 
response to systemic Toxoplasma gondii infection [73]. 
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V. HELICAL CARBON NANOTUBES 
 
Most research regarding CNT toxicity has focused on SWCNTs and MWCNTs 
while other CNT configurations including HCNTs and carbon nanohorns have received 
scant attention. Rapid adaptation and application of SWCNTs and MWCNTs into 
commercial products, along with the development of bulk manufacturing plants to meet 
demand, most likely accounts for this as it quickly raised awareness of these products in 
the toxicology community. Although the straight shapes of SWCNTs and MWCNTs 
allow for multiple applications, non-linear carbon nanotube configurations may be 
superior to straight nanotubes for specific roles. HCNTs are a multi-walled CNT and 
possess similar mechanical properties as other CNTs such as semiconduction and high 
tensile strength. In addition, they show semimetallic characteristics not seen in straight 
CNTs [74] and it is hypothesized that HCNTs may also have superconductive 
properties. Due to their unique shape, HCNTs have demonstrated an elastic spring-like 
behavior under tension [75] and could be developed as mechanical nanosprings. 
Additionally, the helical shape can enhance bonding strength between HCNTs greater 
than straight nanotubes, thus providing increased tensile strength [76]. HCNTs have 
been shown to be superior to SWCNTs as mechanical resonance sensors [77]. 
Conducting electricity through an HCNT results in the generation of an inductive 
magnetic field, which cannot be achieved in straight nanotubes, and thus HCNTs may 
be used to manufacture electromagnetic nanoswitches [76]. Understanding the potential 
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toxicity of HCNTs would allow for the implementation of proper safety protocols prior to 
mass production. 
 
VI. RESEARCH JUSTIFICATION 
 
The inhalation of airborne particulates and subsequent negative impact on 
pulmonary health have been long recognized, with quartz, asbestos, and coal dust 
being some of the earliest and most intensively studied particulates associated with 
pulmonary disease in both environmental and occupational settings. Additional sources 
of airborne particulates have been identified recently and are usually associated with 
the manufacturing of materials composed of titanium dioxide or carbon. Unlike most of 
the airborne particulates studied to date, these newer particulates are often less than 
100 nanometers in diameter. The interaction of nano-sized particulates with biological 
systems likely differs compared to the larger particulates. Accordingly, the field of 
nanotoxicology arose in the early part of the 21st century. 
Studies examining the potential toxicity of carbon nanotubes both in vitro and in 
vivo have produced differing, and sometimes contradictory, results. Much of the 
differences arise from the study design itself including the types of nanotubes used, the 
cell line, and dosing concentration and frequency. Much work has focused on how the 
size, shape, and surface modifications of CNTs changes how they interact with 
biological systems and alters their potential toxicity. It is evident that the potential 
toxicity of a single type of carbon nanotube cannot be applied to all CNTs and thus each 
type of carbon nanotube will require testing for toxicity both in vitro and in vivo. The 
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unique size and shape of the HCNTs used in our studies necessitates the examination 
for potential toxicity. 
One of the interesting facets of CNT toxicity has been how exposure to CNTs 
modulates the pulmonary immune system. Along with other particles, CNTs induce an 
inflammatory response which may be prolonged for many days after a single exposure. 
Along with this inflammatory response, CNTs can potentiate the allergic response. 
CNTs can also suppress the immune response, most notably the T-cell response. 
Additionally, CNTs also can inhibit pulmonary clearance of the pathogen L. 
monocytogenes. However, the inhibition of L. monocytogenes is not observed with other 
particles and CNTs do not alter the immune response to all pathogens. Additionally, 
although L. monocytogenes is a reliable pathogen for studying the immune response, it 
is not considered a pulmonary pathogen except in rare conditions where colonization of 
the lungs occurs following systemic infection. The intersection of the fields of CNT 
toxicology and pulmonary immunity lack studies with known pulmonary pathogens. Our 
study describes the impact CNT exposure has on the pulmonary response to the well-
known pulmonary pathogen P. aeruginosa.  
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VII. FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Synthesis of carbon nanotubes. (A) Synthesis of carbon nanotubes involves 
the rolling of graphite sheets into tubes of various diameters. Multiple layers of graphite 
sheets can be rolled to produce multiple walls (image sources: 
upload.wikimedia.org/wikipedia/commons/8/8c/Graphite-sheet-side-3D-balls.png and 
itech.dickinson.edu/chemistry/?cat=74). (B, C) Representative TEM images of SWCNTs 
(B) and MWCNTs (C) (image source: www.cheaptubes.com).  
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Figure 2. The interaction of particles with the human respiratory tract. (A) Particle 
characteristics. (B) Respiratory tract/particles interactions. (C) Respiratory tract 
characteristics. (Adapted from Bakand S. et al. Inhalation Toxicology, 2012)  
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CHAPTER 2: HELICAL CARBON NANOTUBES ENHANCE THE INNATE IMMUNE 
RESPONSE AND INHIBIT MACROPHAGE-MEDIATED INTERNALIZATION OF 
PSEUDOMONAS AERUGINOSA1 
 
I. ABSTRACT 
 
Aerosolized or aspirated manufactured carbon nanotubes have been shown to 
be cytotoxic, cause pulmonary lesions, and demonstrate immunomodulatory properties. 
In this study, we examined whether helical multi-walled carbon nanotubes (HCNTs) with 
dimensions similar to asbestos fibers could impair internalization and clearance of 
Pseudomonas aeruginosa. HCNTs were readily internalized and found to alter the cell 
metabolism of the mouse RAW 264.7 macrophages at medium and high doses, but only 
caused an increase in cell death at high HCNT concentrations. HCNTs effectively 
inhibited internalization of P. aeruginosa by RAW 264.7 macrophages in vitro. CD-1 
mice were used to assess pulmonary toxicity of HCNTs and alterations of the immune 
response to subsequent infection by P. aeruginosa in mice. HCNTs provoked a mild 
inflammatory response following either a single exposure or 2X/week for three weeks 
(chronic exposure) but were not significantly toxic. Chronic exposure also resulted in 
pulmonary lesions including granulomas and goblet cell hyperplasia. Mice exposed to 
HCNTs and subsequently infected by P. aeruginosa demonstrated an enhanced 
inflammatory response to P. aeruginosa while internalization by alveolar macrophages 
was inhibited. However, clearance of P. aeruginosa was not affected. HCNT-exposed 
                     
1
Reprinted, with permission, from Walling, BE. et al. Helical Carbon Nanotubes Enhance the Early 
Immune Response and Inhibit Macrophage-Mediated Phagocytosis of Pseudomonas aeruginosa, PLOS 
ONE, PONE-D-13-32475R1 10.1371/journal.pone.0080283. 
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mice depleted of neutrophils were more effective in inhibiting P. aeruginosa 
proliferation, accompanied by an influx of macrophages, compared to neutrophil-
depleted control mice. Depletion of systemic macrophages resulted in slightly inhibited 
bacterial clearance by HCNT-exposed mice. Our data indicate that pulmonary exposure 
to HCNTs results in lesions similar to those caused by other nanotubes and pre-
exposure to HCNTs inhibit alveolar macrophage internalization of P. aeruginosa. 
However, clearance was not affected as exposure to HCNTs primed the immune 
system for an enhanced inflammatory response to pulmonary infection consisting of an 
influx of neutrophils and macrophages.  
 
II. INTRODUCTION 
 
Rapid advances in the synthesis of materials on a molecular scale has led to the 
production of a diverse assortment of nanomaterials including CNTs. CNTs are rolled 
up sheets of graphite and can be designed to have a single wall, which are often 1-2 
nanometers in diameter, or multiple walls which can achieve external diameters from 
10-250 nm. Although the diameters of nanotubes are very small, lengths of synthesized 
nanotubes can vary from nanometers to centimeters. CNTs have many distinctive 
physical and chemical properties due to their strong carbon-carbon (C-C) sigma bonds 
and sp2 hybridization, including high tensile strength and thermal and electrical 
conductivity [78]. With multiple potential industrial and medical applications, the demand 
for CNTs has risen rapidly, leading to mass production of nanotubes. However, with a 
size and shape similar to asbestos fibers, concern has been raised for pulmonary 
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toxicity secondary to occupational and environmental exposure [79]. Much research has 
been devoted towards ascertaining the risk of CNT toxicity over the last 15 years 
[80,81]. 
 In addition to direct pulmonary toxicity, investigators have examined how 
inhalation of CNTs may also directly or indirectly modulate pulmonary or systemic 
immunity. SWCNT exposure can activate alveolar macrophages, suggesting that 
nanotubes may enhance pulmonary immunity [82]. Additionally, both SWCNTs and 
MWCNTs have been shown to exacerbate the allergic immune response in mice 
following ovalbumin sensitization [70,83]. However, others have shown that exposure to 
CNTs may suppress the immune response [66-68,84]. Extrapolating from those results, 
one could anticipate that exposure to CNTs would alter and possibly inhibit the immune 
response to microorganisms. One study reported that SWCNT aspiration inhibited 
phagocytosis and decreased pulmonary clearance of L. monocytogenes in mice [57]. 
However, the same SWCNTs had no effect on the early immune response to T. gondii 
infection [73]. Thus, consequences of CNT-induced alterations of the host immune 
response to pathogens are not universal and studies focusing on pulmonary pathogens 
are needed. To date, there has been no published research as to whether or how CNT 
exposure alters the immune response to known pulmonary pathogens. 
Pseudomonas aeruginosa is an opportunistic, ubiquitous, Gram-negative 
pathogen and a major cause of nosocomial pulmonary infections [85]. Pulmonary 
infection by P. aeruginosa in immune-competent individuals is usually self-limiting, 
utilizing a robust acute inflammatory response which initially involves recognition, 
binding, and internalization of the pathogen followed by a release of proinflammatory 
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cytokines as well as chemokines to recruit neutrophils and additional macrophages to 
the lung. The combined efforts of the resident and recruited leukocytes, including direct 
killing of P. aeruginosa and phagocytosis, act to clear the infection from the lungs. 
However, P. aeruginosa is a significant cause of chronic infection and morbidity in 
patients with cystic fibrosis and chronic obstructive pulmonary disease, ventilator-
associated pneumonia, and immunocompromised patients. Given the concern for 
pulmonary exposure to CNTs, the various immunomodulatory properties of CNT 
reported in the literature, and the lack of CNT toxicity research using pulmonary 
pathogens, our lab investigated the effect chronic HCNT exposure had on subsequent 
pulmonary infection by P. aeruginosa in mice.  
 
III. MATERIALS AND METHODS 
 
Chemicals and cell lines 
Chemicals were purchased from Sigma-Aldrich, unless stated otherwise.  The 
murine RAW 264.7 macrophages were purchased from ATCC (#TIB-71). RAW 264.7 
macrophages were maintained in DMEM supplemented with 10% FBS, penicillin, and 
streptomycin and passed at 70-80% confluence. Cells were incubated at 37°C in 5% 
CO2. 
 
Preparation of HCNTs 
HCNTs (Cheap Tubes Inc.) were suspended to 1 mg/ml in dispersal media 
(0.01% Tween-80 in PBS), vortexed, sonicated on ice, and diluted to desired 
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concentrations in DMEM without FBS for in vitro assays.  Dispersion following 
sonication was determined by measuring light absorption at 550 nm. Physical 
characteristics of the starting material were assessed with TEM, SEM, DLS, and Raman 
spectroscopy. Elemental analysis was performed using EDX and XPS (see appendix 1).   
 
Molecular, cytotoxicity, and immunological assays 
Protein concentrations were determined by the BCA protein assay kit (Thermo 
Fisher Scientific Inc.). Lactate dehydrogenase levels were determined by the CytoTox 
96 non-radioactive cytotoxicity assay (Promega). KC and MCP-1 concentrations were 
determined using ELISA kits (R&D Systems). Reactive oxygen species concentrations 
were determined using carboxy-H2DFFDA (Invitrogen). Assays were run following the 
manufacturer’s instructions. 
Cytotoxicity following exposure to HCNTs was determined using a modified MTS 
assay (CellTiter 96 Aqueous One Solution Cell Proliferation Assay, Promega) to 
measure metabolic activity and Trypan blue to quantify cell death. For the MTS assay, a 
modified protocol was used to remove HCNTs which may alter absorption values [86]. 
Cells were seeded in 96-well plates at a density of 2 x 104 cells/well and allowed to 
attach overnight. After washing cells, HCNTs were added at a concentration of 1, 0.1, 
and 0.01 mg/ml and incubated for 6 or 24 hours. Plates were centrifuged at 500 g for 5 
minutes and the supernate was gently removed. CellTiter 96 was added to the wells 
and incubated for 3 hours. Plates were centrifuged again and 120 μl from each well was 
placed into individual microcentrifuge tubes. Tubes were centrifuged for 10 minutes at 
21,000 g and 100 μl of the supernate in the centrifuge tubes was transferred into 96 well 
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plates and read on a spectrophotometer. For Trypan blue assays, RAW 264.7 
macrophages were seeded in 12 well cell culture plates and grown to 70-80% 
confluence. After washing cells, HCNTs were added at a concentration of 1 and 0.1 
mg/ml for 6 or 24 hours. After exposure, the supernate containing detached cells was 
collected, attached cells were trypsanized and pooled with the supernate, and the % 
alive/dead cells were determined using the Trypan blue exclusion assay. 
 
In vitro P. aeruginosa internalization assays 
The internalization of P. aeruginosa by RAW 264.7 macrophages following 
HCNT exposure was quantified by using a gentamicin protection assay as previously 
described [87] and by confocal microscopy.  Initially, 1X106 RAW 264.7 macrophages 
were plated on 6-well tissue culture plates overnight. Macrophages were washed and 
HCNTs were added at a concentration of 0, 10, 25, or 100 μg/ml [88] for 6 or 24 hours. 
After exposure to HCNTs, macrophages were washed to remove nanotubes and 
incubated with P. aeruginosa strain PAO1 in DMEM at a multiplicity of infection (MOI) of 
10:1 at 37°C in 5% CO2. After 1 hour, macrophages were washed and then incubated 
with DMEM containing 100 µg/ml gentamicin for 1 hour to kill off extracellular bacteria 
[89,90]. Macrophages were washed again to remove gentamicin, and lysed with 0.5% 
Triton X-100. Serial dilutions of the lysate were plated onto Pseudomonas isolation agar 
plates and incubated at 37°C overnight. Colonies were enumerated the following 
morning. 
For confocal microscopy, RAW 264.7 macrophages were seeded in wells 
containing autoclaved glass cover slips, (Thermo Fisher Scientific Inc.), allowed to 
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attach overnight, and exposed to HCNTs as described above. After 6 or 24 hours, 
macrophages were washed and incubated with a strain of P. aeruginosa which 
expresses green fluorescent protein (PAO1-GFP) in DMEM at an MOI of 10:1. After 1 
hour, macrophages were washed and fixed with 4% paraformaldehyde overnight at 4ºC. 
Cover slips were mounted on glass slides with Permount mounting media (Thermo 
Fisher Scientific) and macrophages were examined for the presence of internalized 
bacteria by confocal fluorescent microscopy. Samples were placed under an Olympus 
BX50 microscope with a motorized stage and viewed using the Olympus Fluoview 
confocal system using a Melles Griot Argon laser with a 100X oil objective and 
proprietary Olympus "Fluoview" software (FV300 v 5). 
 
HCNT exposure and P. aeruginosa infection in mice  
Animal studies were performed with approval by the Institutional Animal Care 
and Use Committee at the University of Illinois at Urbana-Champaign. Six-week old 
wild-type CD-1 mice (Charles River Laboratories) were housed in positively ventilated 
microisolator cages with automatic recirculating water, located in a room with laminar, 
high efficiency particle accumulation-filtered air. The animals received autoclaved food, 
water, and bedding.  Acute and chronic exposure were performed by intranasally 
inoculating mice with 50 µg of HCNTs in 50 µl of dispersal media or equivalent volume 
of dispersal media alone either once (acute exposure) or twice/week for 3 weeks 
(chronic exposure). Mouse lungs were lavaged or collected for histopathology 24 hours 
after the last treatment. For histopathology, the trachea was exposed and lungs were 
inflated with 1.0 ml 10% neutral buffered formalin (Wako Chemicals) and immersed in 
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10% neutral buffered formalin for at least 24 hours prior to embedding in paraffin. For 
leukocyte enumeration and chemokine levels from the BALF, the trachea was exposed 
and 1.0 ml cold PBS was inserted and removed from the lungs through an 18 gauge 
needle. This first aliquot was placed on ice. The lavage was repeated three more times 
with 1.0 ml and pooled separately. The first aliquot was centrifuged at 500 g for 5 
minutes and the supernate was removed and preserved at -80°C until analyzed for 
chemokine levels. The cells from the first aliquot were resuspended in PBS and pooled 
with the additional 3 ml of BALF for leukocyte enumeration. 
 
Pulmonary clearance of P. aeruginosa. 
Pulmonary clearance of P. aeruginosa was assessed following chronic exposure 
to HCNTs as described above by giving mice a single intranasal dose of PAO1 (1 X 107 
CFU in 50 µl) at 6 or 72 hours following the last HCNT administration [57]. After 24 
hours, mouse lungs were harvested for bacterial enumeration, fixed for histopathology, 
or lavaged for immune cell enumeration and chemokine determination. For bacterial 
enumeration, lungs were aseptically removed and placed on ice followed by 
homogenization in 1 ml cold PBS with a Dounce homogenizer. Homogenate underwent 
serial dilution and plating on Pseudomonas isolation agar.  Colonies were counted 24 
hours later. 
 
Depletion of leukocyte populations 
Depletion of neutrophils was accomplished by IP injection of 0.2 mg anti-Ly6G 
antibody (BioXCell) 48 hours following the last HCNT administration. After 24 hours, 
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mice were inoculated with 1 X 104 CFU PAO1. Lungs were harvested 24 hours later, 
homogenized in PBS, and plated for bacterial enumeration as described above. 
Depletion of systemic macrophages was accomplished by IP injections of 
clodronate liposomes (clodronateliposomes.com) at 72 hours (5.0 mg/mouse) and 24 
hours (1.0 mg/mouse) prior to infection. Mice were inoculated with 1 X 107 CFU PAO1 
and lungs were harvested 24 hours later, homogenized in PBS, and plated for bacterial 
enumeration as described above.  
Neutrophil and macrophage depletion was assessed by analyzing the BAL 
samples and blood smears taken from abdominal venipuncture (n=3-4). 
 
Assessment of P. aeruginosa internalization by alveolar macrophages 
Internalization of P. aeruginosa by alveolar macrophages following chronic HCNT 
exposure was accomplished by giving mice a single intranasal dose of 1 X 107 CFU 
PAO1-GFP 72 hours after the last HCNT exposure as described above. After 1 hour, 
mouse lungs were lavaged for cell collection and enumeration.  
 
Bronchoalveolar lavage leukocyte evaluation 
BAL was performed as previously described [89,91]. Leukocytes were 
enumerated using a hemocytometer and the leukocyte differential was determined 
microscopically following cytospin preparation of leukocytes stained with Kwik-Diff 
(Thermo Fisher Scientific Inc.). At least 200 cells per slide were counted. Cells collected 
for confocal microscopy were concentrated on glass slides by cytospin and fixed with 
4% paraformaldehyde for 1 hour at room temperature. Identification of internalized 
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PAO1-GFP was determined by evaluating at least 200 macrophages by confocal 
microscopy as described above.  
 
Histopathology evaluation of mouse lungs 
Mouse lungs were collected for histopathological analyses as described 
previously [92]. Lung sections were stained with hematoxylin and eosin or with Alcian 
blue and evaluated by a board certified veterinary pathologist. 
 
Statistical analysis 
Normality of the data was evaluated using the Anderson-Darling normality test 
with rejection of normality when p-value < 0.05. Data were then analyzed for statistical 
significance by Student's t-tests, with differences between means considered significant 
when p-value < 0.05. For comparing the means of groups of three or more, data were 
analyzed for statistical significance by ANOVA followed by Tukey’s tests for comparison 
between the means. 
 
IV. RESULTS 
 
Characterization and dispersal of HCNTs  
HCNTs were chosen for our study due to their unique shape in comparison to 
other CNTs. SEM images showed many of the tubes folding into complex structures 
and/or having sharp kinks (Figure 3A). A summary of their physical characteristics is 
shown in Table 1. SEM of the dispersed HCNTs demonstrated a diameter distribution of 
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50-500 nm, with an average about ~200 nm. The length distribution was determined by 
edge extraction from SEM images with NeuronJ [93], finding a range of lengths from 
1.1-2.7 µm with average ~1.9 µm [94]. Using the diameter and length information, the 
SSA of the HCNTs was calculated to be 38.6 ± 28.7 m2/g. XPS revealed that HCNTs 
are comprised of 99.5% carbon, 0.43% aluminum, and 0.08% chlorine. Oxygen was 
also present and likely due to adsorbed water. EDX revealed predominantly carbon and 
trace amounts of iron and oxygen. Because iron was not detected by XPS, it comprised 
< 0.01% of the HCNTs. Full details of the characterization of HCNTs can be found in the 
appendix. 
  Biological effects due to CNTs have, in part, been attributed to their dispersion in 
media. SWCNTs and, to a lesser extent, MWCNTs tend to form agglomerates when 
suspended in solutions such as water or PBS. In vivo, agglomerates have been most 
often associated with the presence of granulomas [44,48] while more dispersed CNTs 
resulted in pulmonary fibrosis [50,95] . Effective dispersal while minimizing agglomerate 
formation as one might find in a natural setting can be achieved using aerosolizing 
chambers, but this can be cost prohibitive. An acceptable alternative frequently used 
involves aspiration of CNTs suspended in media containing a biologically compatible 
dispersant. Artificial surfactant and media containing albumin or serum have been used 
to effectively disperse CNTs for aspiration [95-97].  However, studies have shown that 
proteins can be absorbed on to the surfaces of CNTs, which may alter their biological 
behavior compared to aerosolized CNTs found in an occupational setting [98,99]. To 
avoid this, we used a very low concentration of Tween-80 as a dispersant. Tween-80 
has been used as an effective dispersal agent with no noticeable biologic effects at low 
26 
 
concentrations [70,100]. HCNTs were weighed out and diluted in either sterile PBS (for 
in vivo studies) containing 0.01% Tween-80 or DMEM without phenol (for in vitro 
studies) containing 0.01% Tween-80. HCNTs were vortexed for 15 seconds followed by 
sonication for 5 minutes on ice prior to use or further dilution. CNTs were used in 
experiments within 30 minutes of sonication and briefly vortexed prior to administration. 
The combination of a low concentration of Tween-80 and sonication achieved 
satisfactory dispersal with minimal agglomeration (Figure 3B). 
 
In vitro cytotoxicity of carbon nanotubes 
Our in vitro studies indicate that HCNTs are readily internalized by RAW 264.7 
macrophages, alter cell metabolism, and induce ROS generation but do not significantly 
affect cell viability in concentrations expected to be found in occupational settings. 
Studies examining the cytotoxic potential of CNTs on RAW 264.7 macrophages have 
reached diverse and sometimes contradictory conclusions. Some studies have 
demonstrated direct cytotoxicity [35,41] or indicated that toxicity is dependent on size of 
CNT and cell type [36] while others have suggested that toxicity to RAW 264.7 
macrophages is minimal [33,34,101]. Importantly, establishing in vitro cytotoxicity 
depends in part on the assay used. Earlier reports demonstrated RAW 264.7 
macrophage cytotoxicity following exposure to both SWCNTs and MWCNTs [27,41]. 
However, these relied on an MTT assay for assessment of toxicity, which was shown to 
be potentially inaccurate due to CNTs interacting or absorbing to the dye used in the 
assay [86,102]. To avoid this issue we used an MTS assay, which uses substrates that 
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do not interact with CNTs [86], and modified it to remove the influence of HCNTs on 
measured absorption levels. 
We initially examined the capability for RAW 264.7 macrophages to internalize 
HCNTs. Cytospin preparations of RAW 264.7 macrophages examined under the light 
microscope demonstrated efficacious internalization of HCNTs at a concentration of 0.1 
mg/ml (Figure 4A). HCNTs were readily internalized, with greater than 91% and 99% of 
the macrophages containing HCNTs within the cytoplasm after 6 and 24 hours of 
exposure, respectively (Figure 4B). To assess the cytotoxic potential of HCNTs prior to 
our P. aeruginosa internalization assays, we employed two different methods. First, 
RAW 264.7 macrophages were exposed to HCNTs at concentrations of 0.01, 0.1, or 1 
mg/ml for 6 or 24 hours followed by measuring cell metabolism using an MTS assay 
modified to remove interference by HCNTs [86]. Second, direct visualization of cell 
viability was performed using the Trypan blue dye exclusion assay. HCNTs decreased 
cell metabolism in a concentration dependent manner as determined by the MTS assay 
following both 6 and 24 hours of exposure with a significant decrease observed at 6 
hours at 1 mg/ml and at 24 hours with all three concentrations used (Figure 5A and B).  
However, macrophages appeared resistant to HCNT mediated cell death as the Trypan 
blue assays indicated a decrease in cell viability when RAW 264.7 macrophages were 
exposed to 1 mg/ml but not to occupationally relevant concentrations of 0.01 or 0.1 
mg/ml of HCNTs after 6 and 24 hours (Figure 5C). RAW 264.7 macrophages also 
increased ROS generation after one hour of exposure to HCNTs at concentrations of 
0.1 mg/ml and higher (Figure 5D). Our MTS results, demonstrating decreased cell 
metabolism, are similar to the work of Sohaebuddin et al. but conflict with that of Di 
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Giorgino et al. who reported no reduction in cell viability using that particular assay 
[35,36]. Differences in the types and concentrations of CNTs, cells used, and cell 
culture conditions could account for these disparate results as well as interpretation of 
the results. The results from our Trypan blue assays indicated that decreased cell 
viability was not a prominent sequella to HCNT exposure, although cell metabolism may 
be altered. SWCNTs and MWCNTs have also been reported to decrease RAW 264.7 
macrophage proliferation without affecting cell viability [35,98]. It is speculated that this 
effect may have been, in part, due to CNT agglomeration [81]. At a dose of 0.1 mg/ml 
our results are more consistent with other publications which demonstrated low toxicity 
[34,43,101]. This would suggest that attachment and internalization of HCNTs could 
alter intracellular metabolism without resulting in cell death. Based on these results, we 
used an HCNT concentration from 0.01 mg/ml to 0.1 mg/ml for the P. aeruginosa 
internalization assays with confidence that any changes in phagocytic activity would be 
the result of the influence of HCNTs on viable macrophages and not from loss of 
macrophages due to cell death. 
  
Inhibition of the internalization of P. aeuruginosa by RAW 264.7 
macrophages following HCNT exposure.  
Multiple studies have suggested that exposure to CNTs may impair the host 
immune function [66,68,84] and a few directly addressed whether CNTs may impair the 
phagocytic function of macrophages [30,57,88,103]. However, only Shvedova et al. 
utilized a live microbial organism, L. monocytogenes, which is not typically an inhaled 
respiratory pathogen. We chose to examine whether HCNTs could inhibit internalization 
29 
 
of a known respiratory pathogen, P. aeruginosa. Utilizing PAO1, a strain of P. 
aeruginosa, internalization was decreased following 6 or 24 hours exposure to HCNTs 
in a concentration dependent manner (Figure 6A-B). In a second experiment, RAW 
264.7 macrophages were seeded on coverslips and exposed to HCNTs at a 
concentration of 0.1 mg/ml. The green fluorescent expressing PAO1-GFP was added 
and, following fixation, internalization was examined by confocal microscopy. The 
number of macrophages with internalized PAO1-GFP decreased by ~29 - 39%, 
supporting the results from the gentamicin protection assay that HCNTs had inhibited 
the internalization of P. aeruginosa (Figure 6C-E). 
 
Acute and chronic inflammatory response to HCNTs in vivo 
Without any information regarding HCNT toxicity in the literature, we first 
exposed CD-1 mice to 50 μg of HCNTs either once (acute model) or 2X/week for 3 
weeks (chronic model). Alveolar macrophages readily internalized HCNTs (Figure 7A, 
arrows). Cytological analyses from BALF analyses showed that 71% and 88% of the 
macrophages in the acute and chronically exposed mice, respectively, had internalized 
HCNTs (Figure 7B). However, HCNTs do not appear to be significantly cytotoxic as 
both total protein and lactate dehydrogenase levels in the BALF were not statistically 
different between the HCNT-exposed and control groups following acute or chronic 
exposure (Figure 7C). HCNT exposure resulted in a statistically significant increase in 
the number of neutrophils in the BALF 24 hours after a single inoculum of HCNTs was 
administered and macrophages were elevated in the BALF of mice chronically exposed 
to HCNTs (Figure 8A). Mouse KC, a murine neutrophil chemotactic chemokine 
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homologous to human CXCL1, was significantly elevated in the BALF of acutely (64%) 
and chronically (1593%) HCNT-exposed mice compared to controls. The levels of MCP-
1, a key chemokine which recruits monocytes to sites of inflammation, were not 
significantly elevated in HCNT-exposed mice (Figure 8B). 
 
Chronic exposure to HCNTs induces pulmonary lesions 
Chronic exposure to CNTs has resulted in a variety of pulmonary lesions in 
animal models including granuloma formation, bronchiolar and alveolar fibrosis, and 
goblet cell hyperplasia [104]. In our models, the lungs from control mice receiving 
dispersal media were unremarkable (Figure 9A). In contrast, chronic administration of 
HCNTs resulted in multiple granulomas (Figures 9B and C) in the lungs of mice. HCNT-
laden alveolar macrophages could be found in all lung lobes examined within the 
terminal bronchioles and alveolar spaces (Figures 9D and E). HCNTs also rarely 
penetrated the alveolar septa and were found in alveolar epithelial cells (Figure 9E). 
The lungs from HCNT-exposed mice also contained foci of goblet cell metaplasia, a 
phenomenon reported in other studies of CNT exposure [52-54], which was confined to 
the proximal airways (Figure 9F).  
  
Pulmonary immune response to P. aeuruginosa following chronic HCNT 
administration 
To examine whether chronic HCNT exposure could inhibit clearance of P. 
aeruginosa strain PAO1, we modified a protocol from Shvedova et al. [57].  A cohort of 
CD-1 mice was chronically exposed to HCNTs as described above.  In order to 
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minimize the influence of free HCNTs interacting with pathogens in the alveolar spaces, 
mice were given PAO1 (1X107 CFU/mouse) 72 hours after the last HCNT 
administration. Mice lungs were analyzed 24 hours later. Histologic examination of the 
lungs showed a more robust inflammatory response to PAO1 infection in the HCNT-
exposed mice (Figure 10A) than the dispersal media controls (Figure 10B). Greater 
number of leukocytes, neutrophils, and macrophages were recovered from the BALF of 
HCNT-exposed and infected mice when compared to infected mice that only received 
the dispersal media (Figure 10C). Neutrophil and macrophage chemotactic factors KC 
and MCP-1 were elevated by 47%, and 89%, respectively, in the BALF of HCNT-
exposed mice compared to controls following PAO1 infection (Figure 10D), which 
supported the histologic evidence of enhanced leukocyte trafficking. Interestingly, there 
was no significant difference in the clearance of PAO1 from HCNT-exposed mice 
compared to control mice (Figure 10E). We repeated the experiment and infected the 
mice 6 hours after the last HCNT treatment to minimize egress of HCNT-laden alveolar 
macrophages. Again, there was no significant difference in the clearance of PAO1 from 
HCNT-exposed mice compared to control mice (Figure 10E). To directly assess 
internalization of P. aeruginosa by alveolar macrophages, we repeated the chronic 
exposure protocol, infected mice with PAO1-GFP (1 X 107 CFU/mouse), and recovered 
the alveolar macrophages from the BALF for confocal microscopy. Analysis showed that 
a significantly greater percentage of alveolar macrophages from control mice had 
internalized PAO1-GFP compared to HCNT treated mice (Figure 11). 
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Depletion of select lineages of leukocytes alters the clearance of P. 
aeruginosa in HCNT-exposed mice 
To clarify the roles of neutrophils and macrophages during the immune response 
to P. aeruginosa infection in HCNT-exposed lungs, we used either clodronate liposomes 
to deplete systemic macrophages or anti-Ly6G antibodies to deplete neutrophils. 
Clodronate and Ly6G antibody treatment significantly altered the leukocyte differentials 
in both the BALF and in circulation following PAO1 infection (Table 2). Mice treated with 
anti-Ly6G antibodies had significantly decreased numbers of neutrophils in both the 
BALF and circulation compared to non-depleted mice.  Surprisingly, HCNT-exposed 
mice depleted of neutrophils prior to PAO1 infection had a significantly increase in the 
number of macrophages in the BALF and decreased PAO1 recovered from the lungs by 
1.5 log compared to control mice (Figures 12 A, B). On the other hand, HCNT-exposed 
mice which were systemically depleted of macrophages were less able to clear a PAO1 
infection than control mice by about 0.5 log (Figure 12C). 
 
V. DISCUSSION 
 
In this study, we analyzed the pathogenesis of acute and chronic pulmonary 
exposure to HCNTs and their impact on the pulmonary immune response and clearance 
of P. aeruginosa. Chronic exposure to HCNTs produced lesions in mice similar to what 
has been reported following  exposure to SWCNTs and MWCNTs including granulomas 
[53,105,106] and goblet cell hyperplasia [52-54] as well as elevated proinflammatory 
cytokines [54,105]. Furthermore, our results showed that HCNT exposure can inhibit 
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internalization of P.  aeruginosa by alveolar macrophages. Our aforementioned results 
are similar to those reported by Shvedova et al. [57] following a single administration of 
40 μg of SWCNTs in mice. However, they reported diminished clearance of L. 
monocytogenes following CNT exposure. In contrast, clearance of P. aeruginosa was 
not affected in our study. The lack of inhibition on pathogen clearance by nanoparticles, 
as shown in the current study, is not unique. For example, intratracheal inoculation of 
titanium dioxide nanorods in rats did not affect clearance of L. monocytogenes infection 
[72]. Furthermore, the clearance of L. monocytogenes was enhanced in rats exposed to 
silica particles [71]. Also, SWCNT exposure had no effect on the early immune 
response to T. gondii infection [73]. These results and ours demonstrate that the impact 
of airborne particulates on pulmonary immunity is not uniform and, in part, depends on 
the type and composition of particulates and the host-pathogen relationship. 
 RAW 264.7 macrophages are a functional macrophage cell line transformed by 
the Abelson murine leukemia virus in a BAB/14 mouse [107]. It is one of the most 
commonly used macrophage cell lines in biomedical research and a recent PubMed 
search of the term “raw 264.7 macrophage” resulted in over 3600 results. They readily 
phagocytize multiple targets including latex beads and a broad array of microorganisms 
and have been used to study the binding and uptake of many pulmonary pathogens 
including P. aeruginosa [87,108]. A recent study showed similar expression of multiple 
surface markers including CD11b, F4/80, and CD14 by RAW 264.7 macrophages and 
bone marrow-derived macrophages [109]. Likewise, LPS treatment stimulated higher 
concentrations of TNF-α and RANTES by RAW 264.7 macrophages and bone marrow-
derived macrophages and both cell lines responded similarly to the TLR3 ligand Poly 
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I:C [109]. A direct comparison of surface receptors and/or cell signaling following 
stimulation by ligands between RAW 264.7 macrophages and alveolar macrophages 
has not been published. However, both cell populations express similar receptors for P. 
aeruginosa virulence factors, including TLR4 for lipopolysaccharide and TLR5 for 
flagella [110-112], as well as scavenger receptors for non-opsonic phagocytosis 
[113,114] . Hence, the RAW 264.7 macrophage cell line represents an appropriate 
surrogate for alveolar macrophages to study the inhibition of phagocytosis of P. 
aeruginosa by HCNTs. 
Interpreting the impact of CNT exposure on clearance of pulmonary infections 
must take into account the pathogen used in the individual study. An effective immune 
response to L. monocytogenes infection requires phagocytosis, processing, and 
expression of antigens by macrophages to CD4 and CD8 T cells [115]. Thus 
interference with these functions by CNTs may significantly inhibit clearance. 
Neutrophils, however, are essential in the immune response of P. aeruginosa 
pulmonary infection and failure to do so results in elevated mortality [116,117]. During 
early P. aeruginosa infection, alveolar macrophages are essential for the release of 
neutrophil chemotactic factors [118,119] but the relative contribution of macrophage 
phagocytosis in clearance, although suggested to be important, remains to be 
elucidated in vivo. Our results demonstrated that CNT-induced elevation of both 
neutrophils and infiltrating macrophages (Figure 5C) may compensate for reduced 
macrophage phagocytosis, allowing for efficient clearance of extracellular pathogens.  
 Interestingly, the lungs of mice pre-exposed to HCNTs and depleted of 
neutrophils contained significantly fewer PAO1 (1.5 log) compared to control-neutrophil 
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depleted mice, contrary to what would be expected if HCNTs inhibited macrophage 
function. Examination of the BALF showed that the HCNT-exposed mice contained 
more than twice as many alveolar macrophages than the control mice, suggesting that 
HCNT exposure induced macrophage chemotaxis following infection and the increased 
numbers of macrophages inhibited PAO1 proliferation. By depleting systemic 
macrophages with clodronate, control mice were better able to clear PAO1 infection 
than HCNT-exposed mice, indicating that deficiencies in HCNT-laden alveolar 
macrophage function are also compensated for by recruitment of systemic 
macrophages during infection. 
 Our exposure protocol reasonably reflects what may be expected in an 
occupational setting and is similar to those used in experiments demonstrating 
exacerbation of the immune system in allergy models by CNTs [70] as well the study 
involving the immune response to T. gondii [73]. A previous study has shown that 
approximately 50% of intranasally administered materials reach the lungs of mice [120]. 
Based on this assessment, we estimated the total HCNT deposition in the lungs to be 
~25 µg per treatment and ~150 µg over the three weeks. Using previously published 
estimates of human minute ventilation during light work (20 L/minute) and a 40 hour 
work-week [121], deposition fraction of nano-sized particulates (30%) [53], mouse 
alveolar surface area (0.5 m2) and human  alveolar surface area (102 m2) [53,122],  
calculated equivalent human deposition would be obtained in 8.4 years, 1.1 years, and 
2.7 months when exposed to 53, 400, and 2000 μg/m3, respectively, representing 
airborne concentrations measured from CNT production facilities with various controls 
to limit airborne exposure [53,123,124]. One shortcoming of this estimation is 
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accounting for pulmonary clearance of HCNTs over time. One study in a rat model 
demonstrated that less than 0.15% of a single dose of 100 μg SWCNTs will translocate 
across the pulmonary epithelium [125]. A second rat study showed no change in the 
percentage of alveolar macrophages containing CNTs until 3 months after receiving one 
dose and still found CNTs in macrophages after 6 months [126].  Additionally, the 
presence of HCNTs was evident in more than 88% of alveolar macrophages in our 
study following 3 weeks of exposure. Although it is unlikely that all 150 µg of HCNTs 
administered over 3 weeks were present at the end of the study, the evidence suggests 
that the majority of the nanotubes were still in the lungs. However, if we consider that 
less than 100% of the 150 µg dose is present, this would reduce the calculated 
deposition in humans and the required exposure time.  
 The elevated inflammatory response to pathogens and subsequent clearance 
may depend on the size of CNTs. Although no infection models comparing different 
CNTs have been published, results from ovalbumin sensitized mice suggest that longer 
MWCNTs are more proinflammatory than shorter CNTs [56,127]. Our HCNTs are 
similar in length to long MWCNTs used by Erdley et al. and Nygaard et al. and the 
elevated inflammatory response our HCNTs induced may have compensated for 
decreased internalization by alveolar macrophages. In spite of the potential benefit of 
pathogen clearance, the elevated inflammatory response may also be detrimental to the 
health of the host secondary to pulmonary injury resulting from the enhanced neutrophil 
influx. 
 The mechanisms of CNT-mediated inhibition of phagocytosis remain elusive. 
Physical structure and dose of the CNTs used have been suggested to play a role.  In 
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vitro assays have reported that SWCNTs inhibit phagocytosis to a greater extent than 
MWCNTs at low concentrations [30] and that inhibition of phagocytosis by MWCNTs is 
both diameter and concentration dependent [103]. Shvedova et al. showed a SWCNT 
concentration dependent in vitro inhibition of the phagocytosis of L. monocytogenes by 
alveolar macrophages [57]. However, in vivo phagocytosis was inhibited to a similar 
extent in both the low and high dose groups, suggesting that inhibition of phagocytosis 
and clearance of pulmonary pathogens by CNTs may involve additional mechanisms.  
We have demonstrated that chronic exposure to HCNTs cause pulmonary 
granulomas, fibrosis, goblet cell hyperplasia, and elevates proinflammatory cytokines 
both pre- and post-infection. In addition, HCNTs inhibit internalization of P. aeruginosa 
by RAW 264.7 macrophages and alveolar macrophages. However, a robust innate 
immune response to P. aeruginosa observed in HCNT-exposed mice compensated for 
this defect. This immune modulation appears to require the presence of macrophages, 
as control mice depleted of circulating macrophages were better able to clear infection 
than HCNT-exposed mice. This model represents acute infection of mice chronically 
exposed to HCNTs and our results do not preclude the possibility that HCNT exposure 
may exacerbate chronic infections by P. aeruginosa. Our results and those of others 
show that the pulmonary response and clearance of pathogens following exposure to 
particulates is not uniform and differs by particle type and pathogen used. Thus, 
identifying and establishing relative risk will require studying the interactions between 
additional CNTs and specific pulmonary pathogens. 
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VI. FIGURES 
 
 
  
 
Figure 3. HCNTs resuspended in 0.01% Tween-80 are adequately dispersed prior to 
use. (A) A representative SEM image of HCNTs shows moderate variability in the 
diameter of individual tubes as well as sharp kinks and folding. The circled area 
highlights the diameter measurement using Gwyddion software (see appendix). (B) 
Absorbance as a measurement of dispersion following 5 minutes of sonication. The 
decrease in absorbance over time is from dispersed HCNTs settling by gravity.  A brief 
vortexing resuspends the HCNTs. 
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Figure 4. RAW 264.7 macrophages readily phagocytize HCNTs. (A) A cytospin 
preparation of macrophages exposed to HCNTs shows internalization of HCNTs into 
the cytoplasm by a majority of macrophages. (B) After 6 hours of exposure to a 
concentration of 0.1 mg/ml HCNTs, greater than 90% of macrophages have internalized 
HCNTs. By 24 hours, 99% of the macrophages have evidence of internalized HCNTs. 
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Figure 5. Exposure of RAW 264.7 macrophages to HCNTs results in both a dose and 
time dependent reduction in cell metabolism and generation of ROS. (A-B) A modified 
MTS assay was used to measure cell metabolism after 6 and 24 hours of exposure to 
three concentrations of HCNTs. (C) Cell viability was measured by Trypan blue 
exclusion after 6 and 24 hours of exposure to 0.1 mg/ml and 1 mg/ml HCNTs. (D) ROS 
generation was measured using a carboxy-H2DFFDA assay following exposure to 3 
concentrations of HCNTs after 1 hour. All experiments were performed in triplicate. Data 
from one of three independent experiments are shown. * p < 0.05.  Error bars indicate 
standard error of the mean. 
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Figure 6. HCNTs inhibit internalization of P. aeruginosa strain PAO1 by RAW 264.7 
macrophages in vitro. (A-B) Quantification of the PAO1 by the gentamicin protection 
assay after 6 and 24 hours of exposure of macrophages to 10, 25, and 100 μg/ml 
HCNTs. (C-D) Quantification of the number of macrophages that internalized GFP-
expressing PAO1 bacteria following exposure to 100 μg /ml HCNT. All experiments 
were performed in triplicate and repeated 3 times with similar results. (E) Phase, 
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fluorescent, and merged micrographs of control and HCNT treated cells after exposure 
to GFP expressing PAO1. * p < 0.05.  Error bars indicate standard error of the mean. 
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Figure 7. Acute and chronic exposure to HCNTs results in internalization of HCNTs by 
the majority of alveolar macrophages but is not cytotoxic. (A) Cytospin preparation of 
BALF from an HCNT treated mouse 24 hours after one administration. Many of the 
macrophages have phagocytized HCNTs (arrows). (B) Total protein and LDH levels 
measured from the BALF of mouse lungs acutely (1 day) and chronically (21 days) 
exposed to HCNTs. Black bars = HCNT, white bars = control. n = 3-4 for each group. * 
p < 0.05. Error bars indicate standard error of the mean. 
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Figure 8. Acute and chronic exposure to HCNTs results in changes in the pulmonary 
leukocyte population in mice. (A) Quantitative analyses of the leukocyte populations in 
the BALF 1 day and 21 days after exposure to HCNTs. (B) KC and MCP-1 measured 
from the BALF of mouse lungs acutely (1 day) and chronically (21 days) exposed to 
HCNTs. KC levels were significantly elevated in the BALF following acute and chronic 
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exposure to HCNTs. Black bars = HCNT, white bars = control. n = 3-4 for each group. * 
p < 0.05. Error bars indicate standard error of the mean. 
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Figure 9. Chronic exposure to HCNTs results in multiple pulmonary lesions. (A) Mice 
exposed to the dispersal media (PBS + 0.01% Tween-80) showed no significant 
changes in the bronchi or alveolar spaces. (B) Mice exposed to HCNTs developed 
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multiple granulomas (arrows). (C) A higher magnification of the rectangular inset from B. 
(D) HCNT-laden alveolar macrophages can be found both within the terminal bronchiole 
(arrow) and alveolar spaces. (E) HCNTs can be found within the alveolar walls and 
epithelial cells (arrows) and can be distinguished from epithelial cell nuclei 
(arrowheads). (F) Alcian blue staining of the lungs chronically exposed to HCNTs show 
evidence of goblet cell hyperplasia in the larger conducting airways. Inset is a higher 
magnification of the bronchiolar epithelium. 
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Figure 10. Chronic HCNT exposure enhances pulmonary inflammation without impeding 
clearance of P. aeruginosa. Mice received HCNTs or PBS/Tween-80 twice/week for 3 
weeks. Three days after the last treatment, P. aeruginosa strain PAO1 (1 X 107 
CFU/mouse) was given to all mice. (A-B) Representative images of paraffin embedded 
lungs from mice 24 hours after PAO1 was administered show that HCNT treated mice 
had a more robust inflammatory response (A) compared to control mice (B). (C) 
Leukocyte enumeration and differential counts of cytospin preparations from the BALF 
of mice 24 hours after PAO1 administration shows a significant increase in the numbers 
of neutrophils and macrophages from HCNT treated mice compared to controls. (D) KC 
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and MCP-1 measured from the BALF of mouse lungs after PAO1 infection following 
chronic exposure to HCNTs or dispersal media. All parameters were elevated in HCNT-
exposed mice compared to controls, with MCP-1 reaching statistical significance. (E) 
Clearance of PAO1 in mice was determined by homogenization of whole lungs followed 
by serial dilutions and plating. Mice were infected 6-72 hours after the last HCNT 
treatment. Chronic administration of HCNTs did not affect the clearance of PAO1 from 
the lungs 24 hours after PAO1 infection. Black bars = HCNT, white bars = control. n = 5 
to 6 mice for each group. * p < 0.05. Error bars indicate standard error of the mean. 
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Figure 11. HCNTs inhibit internalization of P. aeruginosa. Alveolar macrophages from 
mouse lungs pre-exposed to HCNTs are less efficient at internalizing PAO1-GFP. n = 3 
mice for each group, a minimum of 200 macrophages were counted per mouse. Black 
bars = HCNT, white bars = control. * p < 0.05. Error bars indicate standard error of the 
mean. 
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Figure 12. HCNT pre-exposure affects clearance of P. aeruginosa in mice depleted of 
specific lineages of leukocytes. (A) Pre-exposure to HCNTs in neutrophil depleted mice 
significantly increased the number of alveolar macrophages in the BALF in response to 
PAO1 infection. n = 5 mice for each group. * p < 0.05. Error bars indicate standard error 
of the mean. (B) HCNT-exposed mice had increased clearance of PAO1 from the lungs 
than control mice when depleted of neutrophils prior to infection. (C) HCNT-exposed 
mice had reduced clearance of PAO1 when systemically depleted of macrophages. 
Black bars = HCNT, white bars = control. n = 8 to 11 mice for each group. * p < 0.05. 
Error bars indicate standard error of the mean. 
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VII. TABLES 
 
 
 
 
 
 
 
 
Table 1. HCNT characteristics. 
  
Table 1. Characteristics of HCNTs 
 
Width µ = 199.9 ± 127.8 nm 
Length µ = 1.9 ± 0.8 µm 
Surface area 38.6 ± 28.7 (m
2
/g) 
Purity > 99.5% carbon 
Zeta Potential -3.04 mV 
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Table 2. Leukocyte differentials following select leukocyte depletion and PAO1 infection. 
  
 Table 2. Leukocyte differentials from the blood and BALF of mice after infection by PAO1 
 Treatment % Neutrophils % Lymphocytes % Macrophages 
 No pretreatment 73.2 ± 2.5 2.2 ± 0.7 24.7 ± 2.4 
BALF Clodronate liposomes 86.7 ± 1.1* 0.7 ± 0.2 12.7 ± 0.9 
 
Anti Ly6G antibody 23.2 ± 4.8*† 2.3 ± 0.3† 74.5 ± 5.0*† 
     
 
No pretreatment 44.3 ± 5.6 34.3 ± 6.5 21.5 ± 2.3 
Blood Clodronate liposomes 56.5 ± 3.8 33.2 ± 2.8 10.3 ± 1.7* 
 Anti Ly6G antibody 2.5 ± 0.8*
† 81.2 ± 3.7*† 16.3 ± 3.5 
Values are means ± SE. n = 3 mice per group. * p < 0.05 vs. no pretreatment. 
† 
p < 0.05 vs. 
clodronate liposomes. 
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CHAPTER 3: HELICAL CARBON NANOTUBES ALTER F-ACTIN DISTRIBUTION IN 
PHAGOCYTIC CELLS AND INHIBIT PSUEDOMONAS AERUGINOSA 
INTERNALIZATION IN AN INTRACELLULAR ACCUMULATION-DEPENDENT 
MANNER 
 
I. ABSTRACT 
 
The mass production of carbon nanotubes (CNTs) has expanded dramatically as 
they are increasing incorporated into commercial products. The small size and similarity 
to the shape of asbestos fibers has raised concern over the potential for pulmonary 
toxicity in occupational and environmental settings. Studies have demonstrated 
pulmonary toxicity associated with exposure, including modulation of the pulmonary 
immune system. Multiple studies have demonstrated impaired phagocytosis of beads 
and bacterial pathogens following exposure to CNTs. However, mechanisms which 
underlie this inhibition have not been studied. We examined whether exposure to helical 
multi-walled CNTs (HCNTs) alters or interferes with cellular structures important in the 
internalization of pulmonary pathogens. Our study shows that inhibition of 
Pseudomonas aeruginosa internalization by RAW 264.7 macrophages and alveolar 
macrophages is directly related to the intracellular accumulation of HCNTs. Additionally, 
the presence of intracellular HCNTs disrupts the normal F-actin distribution in both RAW 
264.7 macrophages and alveolar macrophages in a concentration dependent manner. 
HCNT mediated disruption of F-actin distribution, a key protein in the formation of 
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phagosomes, may explain how CNTs interfere with the internalization of pathogens by 
phagocytes. 
 
II. INTRODUCTION 
 
Production of carbon nanotubes for commercial use has rapidly expanded due to 
successful utilization of CNTs for applications across multiple fields including polymer 
production and electronics. The production methods and ubiquitous presence of CNTs 
has led toxicologists to examine the potential toxicity of CNTs in occupational and 
environmental settings, with a strong concern for pulmonary toxicity [128]. Mouse 
models of CNT toxicity have demonstrated that inhaled CNTs cause pulmonary 
granulomas and fibrosis [43,46,129]. Additionally, CNTs modulate the innate immune 
response, decreasing the ability to fight off pulmonary infections [57,66,84]. This 
impaired immunity has been, in part, attributed to inhibited phagocytosis of pathogens 
by macrophages [57]. However, the mechanisms underlying this inhibition remain 
unclear. 
Alveolar macrophages play an important role in the response to pulmonary 
infections by bacterial pathogens. They act as sentinels in the alveolar spaces and, 
upon encountering pathogens, act by phagocytizing the pathogens and activating a host 
of downstream signals [130]. The actual process of phagocytosis relies on multiple 
subcellular alterations, including the reassembly of F-actin fibers to form pseudopodia, 
which form the phagosome and envelop the pathogen for subsequent processing 
[131,132]. The binding of pathogens by alveolar macrophages, at least during early 
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exposure, differs from systemic infections in that the alveolar spaces are typically bereft 
of IgG and complement, the most common opsonins involved in phagocytosis [133]. 
Instead, phagocytosis by alveolar macrophages is often mediated through non-opsonic 
pathways and uses the scavenger receptors SR-A I/II and MARCO, receptors for 
pathogens [113,114] as well as unopsonized particles [134].  
Successful opsonic and non-opsonic phagocytosis relies on the assembly of the 
cytoskeletal protein F-actin to form the phagosome. Studies have demonstrated that 
ultrafine particles, including TiO2, when taken up by J774A.1 macrophages, result in 
cytoskeletal dysfunction including altered phagosome motility [135]. Furthermore, Kaiser 
et al. described alterations of F-actin filaments in A549 alveolar epithelial cells and 
mesothelioma cells following exposure to raw SWCNTs but not purified CNTs, 
suggesting that the effect was due to presence of catalytic metals or amorphous carbon 
associated with the production of CNTs [136]. However, Holt et al. was able to 
demonstrate that purified SWCNTs could cause actin-related cell division defects and 
SWCNTs altered F-actin structures and focal adhesion complexes in HeLa cells [137]. 
This indicated that purified CNTs can interact and interfere with F-actin distribution but 
suggested that alterations in F-actin distribution by purified CNTs may be limited to 
specific cell lineages. Our work was undertaken to examine how HCNT exposure 
affects F-actin distribution in multiple macrophage cell lines, and if this was dependent 
on the concentration of HCNTs. Additionally, we examined whether inhibition of the 
internalization of P. aeruginosa was related to the accumulation of HCNTs by 
macrophages. 
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III. MATERIALS AND METHODS 
 
Chemicals and cell lines 
Chemicals were purchased from Sigma-Aldrich, unless stated otherwise.  
Actistain-555 was purchased from Cytoskeleton, Inc. Prolong Gold mounting medium 
was purchased from Invitrogen. The murine RAW 264.7 macrophages were purchased 
from ATCC (#TIB-71). RAW 264.7 macrophages were maintained in Dulbecco's 
modified eagle medium (DMEM) supplemented with 10% fetal bovine serum, penicillin, 
and streptomycin and passed at 70-80% confluence. Cells were incubated at 37°C in 
5% CO2. Alveolar macrophages from untreated mice were harvested by 
bronchoalveolar lavage, pooled, resuspended in RPMI, and plated in wells containing 
autoclaved glass cover slips at a density of 5X105 cells per well for 2 hours at 37°C in 
5% CO2 to allow for attachment. 
 
Preparation of HCNTs 
HCNTs (Cheap Tubes Inc.) were suspended to 1 mg/ml in DMEM without phenol 
(Gibco) with dispersal media (0.01% Tween-80 in PBS), vortexed, sonicated on ice, and 
diluted to desired concentrations.  Physical characteristics of the starting material were 
assessed with TEM, SEM, DLS, and Raman spectroscopy. Elemental analysis was 
performed using EDX and XPS (see appendix 1). 
 
 Examination of F-actin distribution following HCNT exposure                                
 RAW 264.7 macrophages were plated in wells with glass cover slips at a density 
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of 1X105 cells/well and allowed to adhere overnight. The following day, macrophages 
were washed and exposed to HCNTs at a concentration of 0, 10, 25, and 100 μg/ml for 
24 hours. Cells were then washed and fixed with 4% paraformaldehyde for 1 hour at 
room temperature. Cells were washed and permeabilized with 0.1% Triton X-100 for 30 
minutes at room temperature. Following permeabilization and washing with PBS, cells 
were incubated for 30 minutes at room temperature in the dark with 100 nM phalloidin 
(a phallotoxin which binds at the interface between F-actin subunits) conjugated to the 
fluorescent dye rhodamine (Acti-stain 555 phalloidin, Cytoskeleton, Inc.). Cells were 
then washed and coverslips were mounted onto glass slides with an antifade mounting 
medium containing 4',6-diamidino-2-phenylindole (DAPI) (Prolong Gold, Invitrogen). 
 Harvested murine alveolar macrophages (see below) were plated in wells with 
glass coverslips at a density of 1X105 cells/well and allowed to adhere over 2 hours. 
The macrophages were then washed and exposed to HCNTs at a concentration of 0, 
10, 25, and 100 μg/ml for 1 hour. Cells were then washed, fixed, permeabilized, stained, 
and mounted as described above. 
 All cells were initially examined for F-actin labeling and distribution using a 
Retiga-200R CCD camera (QImaging) mounted to a Laborlux 12 microscope (Leitz) 
attached to a Lumen 200 illumination system (Prior Scientific) and analyzed with 
ImageProExpress 6.3 software (MediaCybernetics). Confirmation of internalization of 
HCNTs was determined using the Olympus Fluoview confocal system using a Melles 
Griot Krypton laser with a 100X oil objective and proprietary Olympus "Fluoview" 
software (FV300 v 5). 
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In vitro P. aeruginosa internalization assays 
Internalization of a green fluorescent expressing strain of P. aeruginosa (PAO1-
GFP) by RAW 264.7 macrophages following HCNT exposure was evaluated by 
confocal microscopy.  Initially, 1X106 RAW 264.7 macrophages were plated on 6-well 
tissue culture plates overnight. Macrophages were washed and HCNTs were added at a 
concentration of 0.1 mg/ml [88] for 24 hours. After exposure to HCNTs, macrophages 
were washed to remove unbound nanotubes and incubated with PAO1-GFP at a 
multiplicity of infection (MOI) of 10:1. After 1 hour, macrophages were washed and then 
fixed with 4% paraformaldehyde for 1 hour at room temperature. Coverslips were 
mounted on glass slides with Permount and sealed with clear nail polish. Macrophages 
were subsequently examined and enumerated for the presence of internalized bacteria 
by confocal fluorescent microscopy. Sample were placed under an Olympus BX50 
microscope with a motorized stage and viewed using the Olympus Fluoview confocal 
system using a Melles Griot Argon laser with a 100X oil objective and proprietary 
Olympus "Fluoview" software (FV300 v 5). 
 
HCNT exposure and P. aeruginosa infection in mice  
Animal studies were performed with approval by the Institutional Animal Care 
and Use Committee at the University of Illinois at Urbana-Champaign. Six-week old 
wild-type CD-1 mice (Charles River Laboratories) were housed in positively ventilated 
microisolator cages with automatic recirculating water, located in a room with laminar, 
high efficiency particle accumulation-filtered air. The animals received autoclaved food, 
water, and bedding.  Mice were intranasally inoculated with 50 µg of HCNTs in 50 µl of 
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dispersal media or equivalent volume of dispersal media twice/week for 3 weeks. Three 
days after the last HCNT dose, mice were intranasally inoculated with 1X107 CFU 
PAO1-GFP. After 1 hour, mouse lungs were lavaged for cell collection and bacterial 
enumeration. 
 
Bronchoalveolar lavage 
BAL was performed as previously described [89,91]. Briefly, the trachea was 
exposed and 1.0 ml cold PBS was inserted and removed from the lungs through an 18 
gauge needle. This first aliquot was placed on ice. The lavage was repeated three more 
times with 1.0 ml and pooled separately. The first aliquot was centrifuged at 500 g for 5 
minutes and the supernate was removed and preserved at -80°C. The cells from the 
first aliquot were resuspended in PBS and pooled with the additional 3 ml of BALF. 
Cells were concentrated on glass slides by cytospin and fixed with 4% 
paraformaldehyde overnight at 4ºC. Internalization of PAO1-GFP was determined by 
evaluating at least 200 macrophages from each mouse by confocal microscopy. 
 
Measuring intracellular accumulation of HCNTs and PAO1-GFP 
internalization 
To measure the accumulation of HCNTs within the intracellular space of 
macrophages, TIFF images obtained from confocal microscopic examination of 
macrophages were analyzed using Adobe Photoshop software. Individual cells were 
randomly selected and pixel intensity was examined using a histogram, which assigns a 
numeric value for the brightness of individual pixels from 0 (black) to 255 (white). Areas 
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of unencumbered macrophages and extracellular space were used to establish the 
threshold for the darkest pixels not associated with HCNTs. Macrophages with HCNTs 
were then analyzed and the % of pixels with a pixel intensity value below the threshold 
set by the unencumbered macrophages was obtained. HCNT-laden macrophages were 
categorized based on % pixels below the set threshold (i.e. 1-20%, 21-40%, etc.) and 
then enumerated for the presence of PAO1-GFP in the cytoplasm. 
 
IV. RESULTS 
 
Intracellular accumulation of HCNTs by RAW 264.7 macrophages and the 
effect on P. aeruginosa internalization 
Our previous work has shown that HCNTs can inhibit the internalization of P. 
aeruginosa strain PAO1 by RAW 264.7 macrophages. This was, in part, due to an 
overall decrease in the percentage of macrophages which had internalized bacteria and 
led to the question of whether this was a direct result of HCNT accumulation in the 
intracellular spaces of macrophages. Using Photoshop software, we were able to 
determine the percentage of intracellular space occupied by HCNTs. After 6 hours of 
exposure to HCNTs, most of the RAW 264.7 macrophages observed had HCNTs 
occupying 1-20% of their intracellular space (Figure 13A). No RAW 264.7 macrophages 
were observed with > 80% of the intracellular space occupied by HCNTs. After 24 hours 
of exposure, increased numbers of RAW 264.7 macrophages with 21-40% of the 
intracellular space occupied by HCNTs were observed, as well as macrophages with 
>40% occupation (Figure 13B). This indicated intracellular HCNT accumulation 
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increases in RAW 264.7 macrophages over time. Increasing HCNT accumulation was 
associated with a decrease in PAO1-GFP positive RAW 264.7 macrophages following 
both 6 hours and 24 hours of exposure (Figures 13C-D). Interestingly, after 6 hours of 
HCNT exposure, the % of GFP-PAO1 positive macrophages with 1-40% HCNT 
intracellular accumulation was greater than unencumbered macrophages (Figure 13C). 
Additionally, after 24 hours of HCNT exposure, the percentage of macrophages which 
had phagocytized PAO1-GFP was not significantly different between all groups except 
the 80-100% occupation group, which contained no PAO1-GFP positive macrophages 
(Figure 13D).  
 
Intracellular accumulation of HCNTs by alveolar macrophages and the 
effect on P. aeruginosa internalization 
 With the results from our experiments with RAW 264.7 macrophages indicating 
that intracellular accumulation of HCNTs less than 80% of total intracellular area may 
have no effect on internalization of PAO1-GFP, we examined the alveolar macrophages 
harvested from mice following 3 weeks of repeated HCNT exposure and subsequent 
infection. Similar to what was observed with the RAW 264.7 macrophages, the 
distribution of intracellular HCNT accumulation showed that, of those alveolar 
macrophages which had internalized HCNTs, the majority had HCNTs occupying 1-20% 
of the intracellular space with a decreasing percentage of macrophages showing 
increased HCNT accumulation (Figure 14A). This might be expected as alveolar 
macrophages with greater HCNT accumulation might be more rapidly removed from the 
alveolar spaces. Unlike what we observed with the RAW 264.7 macrophages, as HCNT 
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accumulation exceeded 39% of intracellular area, internalization of PAO1-GFP was 
significantly lower than unencumbered alveolar macrophages (Figure 14B). 
 
 
Distribution of F-actin in RAW 264.7 macrophages and alveolar 
macrophages following exposure and internalization of HCNTs 
Prior studies have demonstrated that CNTs may interfere with the cytoskeleton in 
HeLa cells and also can bundle with F-actin filaments [137]. Thus we examined if 
HCNTs altered F-actin distribution in macrophages. We imaged F-actin in unexposed 
and HCNT-exposed RAW 264.7 macrophages and alveolar macrophages using 
rhodamine-labeled phalloidin with both fluorescent wide field and confocal microscopy. 
The F-actin network and distribution in cells undergo frequent changes as cells migrate 
and perform phagocytosis or endocytosis. However, the distribution pattern of F-actin 
and morphology was fairly consistent in cells not exposed to HCNTs. F-actin in 
unexposed RAW 264.7 macrophages was faint with a network of short and thin 
filaments distributed in within the cytoplasm. The fluorescent labeling of F-actin was 
strongest along the cell membrane, most notably within slender projections interpreted 
as filopodia (Figures 15 A and B). Small patches of F-actin were also occasionally 
visualized along the cell membrane and, rarely, in the cytoplasm as small, punctate foci 
(Figure 15B, arrow). The F-actin distribution observed by fluorescent labeling served as 
a basis for comparing macrophages exposed to HCNTs. 
In HCNT-exposed RAW 264.7 macrophages, two prominent changes were 
observed indicating redistribution of F-actin. First, filopodia were less prominent and, 
second, intracytoplasmic aggregation of F-actin was more abundant. The redistribution 
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was more apparent in cells exposed to the highest concentration of HCNTs. RAW 264.7 
macrophages exposed to 10 μg/ml HCNTs for 24 hours showed only minor alterations 
compared to unexposed cells (Figures 15, C and D) but intracellular aggregates of F-
actin were more pronounced in some cells. At 25 μg/ml, filopodia were absent from 
most of the macrophages and the intracellular filament network was rarely present 
(Figure 15E). Additionally, F-actin fluorescent intensity was often strongest when 
associated with HCNTs at the cell membrane (Figure 15F). At the highest HCNT 
concentration (100 μg/ml), RAW 264.7 macrophages had almost no filopodia and 
lacked slender intracellular F-actin filaments. Instead, F-actin was present in large 
aggregates both along the membrane as well as within the interior of the cells (Figures 
15, G and H). Confocal imaging in the x-z plane confirmed that HCNTs were being 
internalized by RAW 264.7 macrophages and associated with F-actin (Figure 16).  
F-actin distribution in alveolar macrophages differed from RAW 264.7 
macrophages. Fluorescent labeling showed asymmetrically distributed punctate 
structures along the leading edge of the macrophages and diffuse, intense fluorescence 
within retraction fibers along the trailing edge (Figures 17, A and B). These punctate 
structures are likely locations of podosomes of the focal adhesion complex, sites of 
anchoring of the cytoskeleton to the extracellular matrix formed at the leading edge of 
migrating cells. This difference in F-actin distribution between alveolar macrophages 
and RAW 264.7 macrophages is likely due to differences in cell motility [138]. Similar to 
what was observed with RAW 264.7 macrophages, exposing alveolar macrophages to 
HCNTs resulted in the redistribution of F-actin within the cell. 
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Alveolar macrophages exposed to HCNTs at a concentration of 10 μg/ml for 1 
hour retained most of the characteristics of unexposed macrophages including 
retraction fibers and fluorescent punctate structures. However, punctate F-actin 
structures were diminished in macrophages with evidence of HCNT internalization 
(Figures 17, C and D). Exposure of alveolar macrophages to increasing concentrations 
of HCNTs resulted in more prominent evidence of F-actin redistribution. HCNT treated 
macrophages at a concentration of 25 μg/ml showed large F-actin aggregates along the 
membrane as well as in the interior of the cells and filopodia were mostly absent 
(Figures 17, E and F). F-actin in alveolar macrophages exposed to100 μg/ml was 
redistributed from the periphery, which lacked any filopodia and podosomes, to the 
cytoplasm and surrounded internalized HCNTs (Figure 17 E). Some macrophages also 
had large intracellular aggregates of F-actin (Figure 17 F). Confocal microscopy of 
fluorescently labeled alveolar macrophages was able to identify large HCNTs curling 
within the cytoplasm of the cells associated with F-actin filaments (Figures 18, A and B). 
Additionally, smaller HCNTs could be identified attached to the cell surface (Figure 
18C).  
 
V. DISCUSSION 
 
In this study, we analyzed potential mechanisms which may explain the inhibition 
of pathogens and particles by macrophages exposed to HCNTs. SWCNTs have been 
shown to inhibit the phagocytosis of apoptotic bodies and L. monocytogenes [57,88]. 
Studies comparing different types of nanotubes showed that both a low dose and high 
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dose of SWCNTs as well as a high dose of MWCNTs inhibited phagocytosis of latex 
beads equally well while a low dose of MWCNTs was not as effective [30]. Furthermore, 
larger diameter MWCNTs inhibited phagocytosis to a greater extent than smaller 
diameter MWCNTs at a similar concentration, a pattern mirroring observed cytotoxicity 
in that study [103]. Phagocytic function was also decreased with increasing 
concentrations of MWCNTs. We have also previously shown that HCNTs inhibit 
internalization by RAW 264.7 macrophages in a concentration dependent manner. 
Our first observation was how intracellular accumulation of HCNTs may affect 
internalization of P. aeruginosa. We observed in RAW 264.7 macrophages following 6 
hours of exposure to HCNTs that the majority of macrophages only had 1-20% of their 
intracellular space occupied by HCNTs with few to rare macrophages containing 
increasing amounts of HCNTs. No macrophages were observed to have greater than 
80% of their intracellular space occupied by HCNTs. At 24 hours, it was evident that 
RAW 264.7 macrophages continued to accumulate HCNTs as an increasing 
intracellular burden was observed. The majority of macrophages had 1-40% of their 
intracellular space occupied by HCNTs. This suggested that macrophages may 
continue to slowly accumulate HCNTs over time. At 6 hours, macrophages with a 1-
40% occupation showed a small but significant increase in phagocytic capacity of 
PAO1-GFP compared to unencumbered macrophages. As the HCNT intracellular 
occupation increased >40%, PAO1-GFP internalization was inhibited compared to 
macrophages with less than 40% occupation but not significantly different than 
unencumbered macrophages. Why the unencumbered macrophages had no advantage 
in the internalization of PAO1-GFP, as a percentage, compared to HCNT-laden 
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macrophages is unclear. Possibly, RAW 264.7 macrophages may tolerate a level of 
HCNT occupation which will not interfere with phagocytosis.  
Intracellular accumulation of HCNTs by alveolar macrophages after 3 weeks of 
repeated exposure in mice followed a similar pattern to RAW 264.7 macrophages, with 
the highest percentage of macrophages containing 1-20% HCNTs and decreasing 
numbers of macrophages showing greater HCNT burdens. However, unlike what was 
observed with RAW 264.7 macrophages, alveolar macrophages with >40% intracellular 
occupation by HCNTs showed impaired internalization of PAO1-GFP compared to 
unencumbered alveolar macrophages. This would suggest that alveolar macrophages 
may only tolerate a low burden of HCNTs which will not affect certain immune functions. 
Additionally intracellular accumulation of HCNTs in alveolar macrophages may, in part, 
impair internalization of PAO1-GFP to a greater extent than RAW 264.7 macrophages.  
 Phagocytosis of particles and pathogens is an actin-dependent process which 
involves the binding of targets to surface receptors followed by remodeling of the actin 
cytoskeleton [132]. The essential role of F-actin in this process has been demonstrated 
using the inhibitor cytochalasin D, which blocks F-actin polymerization [139]. Binding of 
opsonins to their receptors results in the activation of multiple downstream signals such 
as Rac1 and Cdc42 following activation of the receptors for immunoglobulins [140,141] 
and Rho and Rap 1 after activation of complement receptors [142,143]. Both result in 
the remodeling of F-actin filaments by depolymerization and repolymerization acting 
through multiple proteins such as ARP 2/3, gelsolin and cofilin. Furthermore, 
phagocytosis of complement-bound particles depends on microtubule assembly and 
inhibition of microtubule polymerization by nocodazole inhibits complement mediated 
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phagocytosis [144].  Scavenger receptor dependent phagocytosis also requires F-actin 
polymerization [145] and, similar to complement-mediated phagocytosis, requires 
functional microtubules for the internalization of bound targets [146]. Thus effective 
phagocytosis relies on the coordinated depolymerization and repolymerization of F-actin 
through a series of signaling molecules, adaptor proteins, and additional components of 
the cytoskeletal structure.  
Our study has demonstrated altered F-actin distribution in both RAW 264.7 
macrophages and alveolar macrophages and, in some cases, identified intense 
localization of F-actin around individual nanotubes. Our observations are similar to F-
actin distribution from the cortex to random intracellular projections observed in HeLa 
cells exposed to SWCNTs [137]. Along with a separate study showing alterations in the 
cytoskeleton, and F-actin in particular, by ultrafine particles which resulted in altered 
phagosome trafficking [135], this suggests that HCNTs themselves may interfere with 
proper F-actin reorganization following binding of pathogens to macrophage receptors. 
However, HCNT exposure may also impact other proteins involved in internalization 
such as paxillin and vinculin and SWCNTs have been shown to alter paxillin structures 
in HeLa cells [137]. This is important because the actin-paxillin structures, which 
represent stress fiber focal adhesion complexes, may play an important role in receptor-
mediated phagocytosis [147]. Paxillin phosphorylation also couples scavenger receptor-
A to the formation of focal adhesion complexes and the actin cytoskeleton [148] 
however its role in scavenger receptor phagocytosis has not been determined. 
Additionally, CNT alterations of microtubule distribution, which are important in non-
opsonic and complement mediated phagocytosis, have not been explored. 
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VI. FIGURES 
 
 
Figure 13. Intracellular accumulation of HCNTs inhibits the percentage of RAW 264.7 
macrophages which have phagocytized PAO1-GFP. Macrophages were exposed to 0.1 
mg/ml HCNTs for 6 or 24 hours prior to incubation with GFP-PAO1. (A, B) The 
distribution of macrophages based on the percentage of the intracytoplasmic area 
occupied by HCNTs following 6 or 24 hours of HCNT exposure. After 24 hours, the 
accumulation of macrophages by HCNTs as a function of intracytoplasmic area has 
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increased. The accumulation of intracytoplasmic HCNTs was determined in a minimum 
of 750 macrophages for each time point. (C, D) Increased intracellular accumulation of 
HCNTs decreased the percentage of macrophages that have internalized PAO1-GFP 
after 6 or 24 hours of HCNT exposure. Macrophages which had accumulated enough 
HCNTs to occupy 1-40% of the intracellular area after 6 hours of exposure showed a 
slightly increased ability to internalize PAO1-GFP (C). After 24 hours of exposure, 
internalization of PAO1-GFP as a function of HCNT occupation was not significantly 
different between all groups except for macrophages with 81-100% occupation (D). 
Horizontal bars in C and D indicate the percentage of PAO1-GFP positive RAW 264.7 
macrophages which were not exposed to HCNTs run in parallel with the HCNT- 
exposed macrophages for 6 or 24 hours. n = 3-4 for each group and a minimum of 200 
macrophages were evaluated. * p < 0.05 compared to HCNT-exposed macrophages 
with no evidence of HCNT accumulation. Error bars indicate standard error of the mean.  
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Figure 14. Intracellular accumulation of HCNTs decreases the percentage of alveolar 
macrophages which have internalized PAO1-GFP compared to unencumbered 
macrophages. (A) Following 3 weeks of repeated exposure to HCNT and subsequent 
infection, the majority of alveolar macrophages harvested from mice have 1-20% of their 
intracellular space occupied by HCNTs. The accumulation of intracytoplasmic HCNTs 
was determined in 1000 macrophages. (B) Increasing HCNT burden in alveolar 
macrophages decreased the percentage of macrophages with visual evidence of 
internalization of PAO1-GFP. Horizontal bars B indicate the percentage of PAO1-GFP 
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positive macrophages recovered from mice not exposed to HCNTs run in parallel. n =4 
for each group and a minimum of 200 macrophages were evaluated from each 
individual. * p < 0.05 compared to HCNT-exposed macrophages with no evidence of 
HCNT accumulation. Error bars indicate standard error of the mean. 
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Figure 15. Exposing RAW 264.7 macrophages to HCNTs results in altered cellular 
morphology and F-actin distribution. (A, B) Fluorescent labeling of F-actin is strongest in 
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filopodia. Some cells contain small, punctate aggregates in the cytoplasm (B, arrow). 
(C, D) Macrophages exposed to HCNTs at a concentration of 10 μg/ml show some 
subtle alterations in cell morphology. Filopodia are less frequent and slightly larger 
aggregates of F-actin can be found (C, arrow). (E, F) Most macrophages exposed to 
HCNTs at a concentration of 25 μg/ml have blunt filopodia compared to unexposed 
macrophages. In some cells, F-actin surrounds HCNTs (F, arrow). (G, H) Macrophages 
exposed to HCNTs at a concentration of 100 μg/ml showed marked changes in F-actin 
distribution. Macrophages have almost no filopodia and lacked slender intracellular F-
actin filaments. Instead, F-actin was present in large aggregates both along the 
membrane as well as within the interior of the cells (H, arrow). 
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Figure 16. Confocal microscopy confirms the presence of HCNTs within RAW 264.7 
macrophages. Examination of the x-z plane of macrophages with rhodamine labeled F-
actin identifies HCNTs within the cells (A, B, arrows 
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Figure 17. Exposing alveolar macrophages to HCNTs results in altered cellular 
morphology and F-actin distribution. (A, B) Fluorescent labeling showed asymmetrically 
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distributed punctate structures (podosomes) along the leading edge of the 
macrophages (arrowhead) and diffuse, intense fluorescence within retraction fibers 
along the trailing edge. (C, D) Alveolar macrophages exposed to HCNTs at a 
concentration of 10 μg/ml showed minimal changes compared to unexposed 
macrophages although punctate accumulations of F-actin was diminished in cells with 
evidence of HCNT internalization (arrow). (E, F) Alveolar macrophages exposed to 
HCNTs at a concentration of 25 μg/ml show alterations of F-actin distribution including 
the absence of punctate accumulations and the formation of large intracellular and 
membrane associated aggregates (arrow). (G, H) Alveolar macrophages exposed to 
HCNTs at a concentration of 100 μg/ml showed marked changes in F-actin distribution 
with most F-actin located within the cytoplasm often surrounding foci of HCNT 
accumulation (arrow). 
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Figure 18. Confocal microscopy confirms the presence of HCNTs within alveolar 
macrophages. (A, B) Large HCNTs can be found curling within the intracellular space 
with F-actin filaments adjacent to the HCNTs (arrows). (C) HCNTs also appear attached 
to the cell surface (arrowhead). 
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CHAPTER 4: SUMMARY 
 
For my preliminary examination I proposed two hypotheses: 1. HCNTs interfere 
with the internalization of the pulmonary pathogen Pseudomonas aeruginosa and 2. 
HCNTs impair clearance of P. aeruginosa infection in the lungs. As observed in chapter 
2, my results confirmed hypothesis #1 but hypothesis #2 was shown to be false. Based 
on the results of my first two hypotheses, two more hypotheses were generated: 3. 
Exposure to HCNTs enhances the acute inflammatory response to P. aeruginosa 
infection and 4. HCNTs alter F-actin distribution in macrophages, which is a key protein 
required for phagocytosis of P. aeruginosa. The results in chapters 2 and 3 support my 
hypotheses. 
For my first hypothesis, I initially established the potential cytotoxicity of HCNTs 
both in vitro using RAW 264.7 macrophages and in vivo in mouse models. Based on 
published literature, CNT cytotoxicity varies between cell lines and the CNTs used; thus, 
it was important to determine if the HCNTs, a novel type of nanotube, were cytotoxic 
towards RAW 264.7 macrophages and, if so, at what concentration. The rationale 
behind this was if HCNTs were toxic to cells, the assays to determine internalization 
would be unreliable. My results indicated that cytotoxicity was only significant at an 
exposure concentration of 1.0 mg/ml which is well beyond what would be expected in 
occupational settings. Lower concentrations of HCNTs are not benign, as both the 
assays measuring cell metabolism and reactive oxygen species generation 
demonstrate. However, cell death was not significant at concentrations of 0.1 mg/ml 
and, thus, this dose was established as our high exposure dose for subsequent 
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experiments. The next set of experiments, utilizing the gentamicin protection assay, 
established that HCNTs inhibit internalization of P. aeruginosa by RAW 264.7 
macrophages in a concentration dependent manner. A follow up assay using GFP-
PAO1 and confocal microscopy determined that this was the result of fewer 
macrophages internalizing P. aeruginosa. 
For my second hypothesis I initially examined the pulmonary response to HCNT 
administration in mice. A single exposure to HCNTs caused a mild influx of neutrophils 
into alveolar spaces, which coincided with an increase in the neutrophil chemotactic 
factor KC. Repeated exposure over three weeks resulted in a mild increase in alveolar 
macrophages as well as the development of pulmonary lesions consistent with the 
persistence of foreign material, including granulomas. However, commonly used indices 
of pulmonary toxicity, protein and lactate dehydrogenase in the BALF, showed no 
significant toxicity following exposure to HCNTs. We also showed that 3 weeks of 
repeated exposure to HCNTs inhibited internalization of GFP-expressing PAO1 in a 
similar pattern to that observed by RAW 264.7 macrophages in vitro. However, 
pulmonary clearance of PAO1 was not affected by pre-exposure to HCNTs. 
Additionally, the acute inflammatory response to PAO1 infection was more pronounced 
in HCNT-exposed mice compared to control mice accompanied by a significant 
increase in neutrophils and macrophages and elevations of chemotactic factors in the 
BALF. Our conclusion from these experiments was that HCNTs impair internalization of 
P. aeruginosa by alveolar macrophages but enhance the innate inflammatory response 
to P. aeruginosa, a phenomenon also observed in rats exposed to silica [71]. 
 
81 
 
Our in vivo results encouraged us to explore this phenomenon further. Our 
hypothesis was that macrophage function was still impaired but masked by the 
additional influx of neutrophils. Studies have demonstrated that a robust neutrophil 
response is necessary in order to clear an acute P. aeruginosa infection [116]. Failure to 
do so significantly increases mortality, as demonstrated in neutrophil-depleted mouse 
models. We repeated our in vivo experiments and included depletion of neutrophils or 
systemic macrophages just prior to infection. The results from our neutrophil depletion 
studies showed a decreased recovery of PAO1 from the lungs of HCNT-exposed mice 
compared to control mice by about a 1.5 log difference and BALF from the HCNT-
exposed mice contained more macrophages than control mice. Our conclusion was that 
the HCNT-exposed/neutrophil depleted mice were able to recruit more circulating 
macrophages following infection than control mice, again demonstrating the priming of 
the immune response by HCNTs. Our subsequent experiment with mice exposed to 
HCNTs and depleted of systemic macrophages showed decreased clearance of PAO1 
compared to control mice, although the difference was less than 1 log, suggesting a 
minor role for circulating macrophages in response to pulmonary infections. The 
contribution of recruited macrophages to the innate immune response following P. 
aeruginosa infection has not been studied. 
The influence of CNTs on the expression of cytokines both in vitro and in vivo 
has been described in multiple studies, although the conclusions are mixed. Exposure 
to MWCNTs, SWCNTs, or single-walled carbon nanohorns failed to increase mRNA 
expression of the proinflammatory cytokines IL-1β, CXCL-9, IL-6, MIP-1α, or TNF-α in 
RAW 264.7 macrophages [34,149] although CXCL2 secretion was elevated in one 
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study [41]. However, SWCNT exposure increased TNF-α production by zymosan-
stimulated RAW 264.7 macrophages [33], which would suggest that, rather than being a 
direct stimulator of proinflammatory cytokine production, CNTs may amplify the 
response to other proinflammatory mediators. CNT exposure in animal models also has 
demonstrated mixed results. A single exposure to SWCNTs elevated multiple 
proinflammatory cytokines three days post inoculation including IL-5, IL-6, MIP-1α, KC, 
MCP-1, and RANTES but failed to elevate TNF-α, IL-1β, or IL-17 [57]. The same study, 
thought, did demonstrate elevated IL-1β and IL-17 following SWCNT exposure and 
subsequent L. monocytogenes infection. Levels of IL-1β, IL-6, IFN-γ, TNF-α, and MCP-
1 in the BALF of SWCNT exposed mice were not significantly different than untreated 
controls after 8 days [73]. A separate study showed that SWCNTs elevate IL-6 mRNA 
expression and MWCNTs elevate IL-1β, IL-6, and CXCL2 expression in the lungs of 
C57BL/6 mice after 4 hours [56]. TNF-α and IL-17 protein levels in the BALF of BALB/c 
mice were elevated 24 hours after a single exposure to MWCNTs but were not 
significantly elevated after 7 days [54]. Likewise, a single treatment of MWCNTs had no 
effect on lung mRNA levels of TNF-α or CXCL2 7 days after exposure [41]. The results 
from these studies suggest that 1) CNTs alone provoke a transient increase in 
proinflammatory cytokines which rapidly resolves and 2) CNTs can amplify the 
proinflammatory cytokine levels following pulmonary infections in mouse models. We 
observed a similar phenomenon in our mouse model of HCNT exposure and P. 
aeruginosa infection and examination of additional proinflammatory cytokines in our 
models might further elucidate our results. 
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Another unexplored facet of CNT-mediated inhibition of pulmonary clearance of 
pathogens includes the potential alteration of macrophage function by IL-10. IL-10 acts 
as an anti-inflammatory cytokine and is crucial in modulating/controlling the 
inflammatory response with a broad array of effects on the monocyte/macrophage 
population which has been extensively reviewed [150]. Among many functions of IL-10, 
it inhibits production of multiple proinflammatory cytokines including IL-1β, IL-12, and 
TNF-α by monocytes/macrophages [151-153]. Additionally, it can inhibit the production 
of chemotactic chemokines including MCP-1, RANTES, and KC [154,155] and inhibit 
prostaglandin E2 production [156]. IL-10 also enhances production of IL1-RA and 
soluble p55 and p75 TNFR, which antagonize the proinflammatory mediators IL-1 and 
TNF [157,158]. IL-10 also indirectly inhibits nitric oxide production by inhibition of 
endogenous TNF and IFN-γ synthesis [159,160]. Finally, IL-10 downregulates 
expression of TLR4 [161] and upregulates expression of CD14, CD16, CD64, and 
CD163, a scavenger receptor expressed by monocytes and macrophages [162]. The 
net effect results in differentiation of macrophages which subsequently limit ongoing 
inflammation and resolve infections [150]. In mouse models, SWCNTs failed to result in 
any elevation of IL-10 in the BALF 3 or 8 days after exposure [57,73]. However, IL-10 
mRNA was elevated in the lungs by both SWCNTs and MWCNTs 4 hours post-
exposure. Additionally, IL-10 mRNA was elevated in laser-capture isolated 
macrophages associated with MWCNT-induced pulmonary granulomas [47]. Potentially, 
chronic exposure to CNTs may elevate IL-10 levels in the lungs which could explain 
impaired clearance of pathogens. Studies have also shown that NO production is 
decreased in alveolar macrophages exposed to SWCNTs 3 days after exposure and 
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was suggested as one reason for impaired clearance of L. monocytogenes [57]. 
Additional studies examining how HCNTs affect NO generation and IL-10 production 
would be of interest. 
The uptake of ultrafine particles has been reported to cause cytoskeletal 
dysfunction including the impairment of phagocytosis and inhibition of intracellular 
transport [135]. Although such disruption would suggest impaired actin and/or 
microtubule function, this has not been fully explored. Our studies show that exposure 
to HCNTs disrupts normal F-actin localization in a dose dependent manner and others 
have shown that SWCNTs can bundle purified F-actin [137]. How the bundling of F-
actin by CNTs disrupt normal distribution is unknown. Initial experiments utilizing 
methods to measure F-actin polymerization/depolymerization in the presence of HCNTs 
could be applied. Additionally, electron microscopy could (and will) be employed along 
with gold-labeled actin to examine this phenomenon. Uptake of particles and pathogens 
by complement and scavenger receptors also requires microtubule assembly. The 
impact of HCNTs on microtubules in phagocytic cells has not been thoroughly examined 
and provides us with another target worth exploring. 
In addition to F-actin, the formation of the phagosome around receptor bound 
pathogens utilizes a host of important proteins which work in concert to disassemble 
polymerized F-actin and reassemble F-actin around the phagocytic cups. These 
proteins are also important in the formation of stress fibers. Paxillin is a focal adhesion-
associated signaling molecule which acts as an adaptor protein involved in cytoskeleton 
assembly [163]. Paxillin co-localizes with F-actin at the anchoring sites of focal adhesion 
complexes, along with vinculin [164], and is involved in the regulation of cell motility 
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[165]. Studies have suggested that vinculin and paxillin are involved in immunoglobulin 
and complement mediated phagocytosis [147,166]. Additionally, paxillin becomes 
redistributed in cells treated with SWCNTs [137]. Examination of paxillin and vinculin 
distribution following HCNT exposure in our cells would help confirm the impact HCNTs 
have on F-actin distribution. 
The binding and engulfment of foreign particles and pathogens is a fundamental 
role of macrophages and a key step in the induction of the host immune response 
following infection by P. aeruginosa [167]. Opsonin-mediated phagocytosis involves the 
binding of foreign particles by small molecules followed by attachment to specific 
receptors and is the predominant mechanism of phagocytosis by macrophages during 
invasive infections. Immunoglobulins and complement are the two most prominent 
opsonins which coat foreign particles and increase their susceptibility to phagocytosis 
by binding to Fc receptors and complement receptors, respectively. The binding of 
opsonins to pathogens and their receptors triggers downstream signals resulting in the 
formation of the phagosome and engulfment of the target. However, the lower airways 
typically contain negligible levels of complement and immunoglobulin and resident 
macrophages have very low expression levels of complement receptors [133]. Thus it is 
likely during a pulmonary infection by P. aeruginosa the alveolar macrophages rely on 
alternative opsonins, such as the surfactant proteins [91,168] as well as non-opsonic 
phagocytosis. Non-opsonic phagocytosis utilizes a separate set of macrophage 
receptors which were initially described as mannose receptors [169]. However, another 
family of receptors, identified as scavenger receptors, appears to play a very important 
role both in the phagocytosis of pathogens and clearance of particulates.  To date, 13 
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different scavenger receptors have been identified with 9 of them showing affinity for 
binding pathogens [170].  
MARCO is a class A scavenger receptor found on the surface of macrophages 
and plays an important role in the binding and phagocytosis of extracellular targets. The 
class A scavenger receptors can bind directly to unopsonized targets, which is crucial in 
locations with low or negligible levels of complement or immunoglobulin such as the 
alveolar spaces. MARCO is only constitutively expressed at high levels in certain 
macrophage subpopulations including the splenic macrophages in the marginal zone of 
the spleen and medullary macrophages of lymph nodes [171] as well as peritoneal 
macrophages. However, MARCO can be rapidly upregulated in resident macrophages 
of the liver, lymph nodes, and lungs during bacterial infections [172]. LPS can also 
stimulate expression of MARCO in dendritic cells [173] and glial cells [174] as well as 
the murine macrophage cell lines J774A.1 and J774.2 [172]. Targets for MARCO 
include gram positive and gram negative pathogens. MARCO is an important for the 
host response to Streptococcus pneumoniae [114], and alveolar macrophages 
pretreated with a specific inhibitor of MARCO showed a defect in the engulfment of P. 
aeruginosa. Alveolar macrophages also use MARCO to scavenge for inhaled 
particulates. MARCO recognizes and binds particulates including TiO2, Fe2O3, and latex 
beads [134,175] and specific inhibition of MARCO by monoclonal antibodies 
significantly reduced binding  and uptake of TiO2, iron oxide, and latex beads 
[114,134,176]. MARCO-transfected CHO-K1 cells also demonstrated enhanced uptake 
of MWCNTs [177], suggesting that phagocytosis of inhaled nanotubes by alveolar 
macrophages may be facilitated by MARCO.  
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The scavenger receptors SR-AI/II have similar structures to MARCO [178] and 
also fulfill similar functions. The loss of the SR-A’s results in increased susceptibility to 
Staphylococcus infection [179]. Additionally, SR-AI/II binds unopsonized E. coli and 
Streptococcus pyogenes to facilitate phagocytosis [180,181]. More recently, Wang et al. 
demonstrated that selective blocking of SR-AI/II on the surface of RAW 264.7 
macrophages inhibited MWCNT mediated apoptosis, demonstrating that the SR-A’s 
bind MWCNTs [182]. The SR-A’s also have been identified as an important receptor 
expressed by alveolar macrophages to facilitate particle uptake [113,183] as well as 
contribute to the innate defense against pulmonary pathogens [113]. The role of the SR-
A’s in the binding and uptake of P. aeruginosa has not been explored. 
In summary, the results of our studies have demonstrated that HCNTs can inhibit 
internalization of P. aeruginosa and that inhibition is, in part, a result of the accumulation 
of HCNTs in the intracellular space and that HCNTs disrupt the normal distribution of F-
actin, an essential component of the phagocytic machinery. Knowing that normal F-actin 
distribution can be disrupted, proteins with roles in F-actin anchoring and remodeling for 
movement and phagocytosis, including vinculin and paxillin, may also be affected by 
HCNT accumulation and are worthy of examination. Additionally, the effect of HCNTs 
on microtubule assembly and distribution has not been explored. Finally, because both 
CNTs and pathogens bind to scavenger receptors MARCO and SR-A I/II and that 
scavenger receptors are important for non-opsonic phagocytosis, further studies 
examining how HCNT exposure alters scavenger receptor expression and/or binding of 
P. aeruginosa are warranted.  
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APPENDIX 
 
I. HCNT CHARACTERIZATION AND ANALYSIS 
 
Bright field TEM images were acquired on a JEOL JEM2100 microscope 
operated at 200 kV with a spherical aberration coefficient of 2.0 mm (Figure 19). The 
nanotubes were prepared by sonication in ethyl alcohol for 5 minutes on ice, vortexed, 
and dispersed on copper grids coated with Formvar plastic. A Hitachi S-4800 field 
emission scanning electron microscope was used to analyze the structural features of 
HCNTs. HCNTs were pressed onto double-sided carbon tape and imaged under a 5.0 
kV accelerating voltage at varying magnifications (Figures 20A i-iv). HCNTs were also 
dispersed in 2% wt/vol SDS by centrifugation followed by vacuum filtration onto 
nitrocellulose membranes. The HCNTs were then transferred to a SiO2/Si supporting 
substrate for SEM analysis (Figures 20A v and vi). The diameter distribution was then 
obtained by importing the SEM files into Gwyddion (http://gwyddion.net/) [184]. Line 
profiles were taken perpendicular to the longitudinal axis of the HCNTs, ensuring that 
the profile ended at the HCNT edge. An example line profile is encircled in Figure 20A 
v. The HCNTs have a diameter distribution of 50-500 nm, normally distributed about 
~200 nm (n = 80) (Figure 20B).  
Additionally, we determine the lengths of the HCNTs by edge extraction with 
NeuronJ [93]. We use SEM images gathered in the same way as Figure 20A i-vi to 
extract the HCNT length. By analyzing the distance between maxima in the HCNTs’ 
helices, we calculate the helical pitch to be ≈ 12 nm. With the SEM images in Figure 
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21A i-vi and NeuronJ, the apparent HCNT length is Lapp = 1.40 ± 0.53 µm (n = 50). To 
determine the actual HCNT length, that is, the length of the unraveled helix, we employ 
the expression, where “a” is the HCNT radius (~100 nm) and “b” is the helical pitch (~12 
nm). Therefore, the helical length distribution is LHCNT = 1.9 ± 0.8 µm, as shown in 
Figure 21B. The difference between the helical length LHCNT and the apparent length 
Lapp is ΔL = LHCNT – Lapp. ΔL ranges from 0 to 1.46 µm, with a mean at 0.5 µm. 
Using the diameter and length information, we can estimate the SSA of the 
HCNTs. The interior core of HCNTs has previously been shown to be hollow [185]. 
There is a dense array of MWCNTs that surrounds this hollow core, and the hollow core 
is ~2 nm in dimension [78,185]. The thickness of a MWCNT is that of graphene (0.34 
nm) and the separation between walls in a MWCNT is ~0.35 nm [78]. Therefore we can 
calculate the number of shells within the HCNTs by subtracting the hollow core’s 
contribution from the radius distribution (RHCNT = 100.0 ± 63.9 nm) and dividing by 0.7 
nm per shell. We estimate the number of shells to be NS = 143 +/- 91. The SSA, is then 
given by the modified [94] equation: 
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From eq. [1], the number of shells Ns, the diameter distribution dHCNT, and the length 
distribution ΔL, the range of SSA values is SSA = 38.6 ± 28.7 m2/g. Comparatively, the 
bulk SSA value from the manufacturer, extracted by Brunauer-Emmett-Teller (BET) 
analysis, was SSA >30 m2/g (www.cheaptubesinc.com). 
  Elemental analysis of small regions of the HCNTs was performed by EDX using 
a Philips XL30 environmental SEM (ESEM) with an EDX column. Samples were 
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prepared by impregnating a Si surface with a piece of Scotch tape covered with HCNT 
powder. EDX (Figure 22) reveals the Si substrate and the presence of C. The O and Fe 
signals are weak and just above the noise floor of the instrument. Still, we hold that 
these are real, and thus there are trace amounts of O and Fe within the HCNTs. The O 
likely resulted from the oxidized Si surface and adsorbed O2 on the HCNTs. It is also 
possible that the HCNTs’ sidewall defects could be terminated with oxygen. The Fe 
results from the growth processes involved in generating the HWCNTs.  
Additional chemical analysis of HCNTs was performed by XPS using a KRATOS 
Axis Ultra 165 mm X-ray photoelectron spectrometer, and carried out on a small amount 
of HCNTs deposited on vacuum compatible 3M copper conductive tape (Pella product 
no. 16074). The XPS survey spectrum (Figure 23A) shows the presence of O, C, Cl, 
and Al. The presence of O is likely due to adsorbed water, as the XPS survey does not 
indicate the presence of carbon functional groups related to the poly-acrylate adhesive 
of the conductive copper tape used during XPS analysis. High resolution C-1s XPS 
spectra (Figure 23B) shows components at 284.5 eV (HCNTs) and 290 eV (satellite 
peak for graphitic carbon).  The intensity of the HCNT peak was determined by fitting 
the C-1s region collected at an electron emission angle of 0° using a Shirley 
background and a Doniach-Sunjic line-shape for the helical HCNT. This is based upon 
fits of the C-1s of highly ordered pyrolytic graphite (HOPG) [186]. The presence of Cl 
and Al (Figures 23 C and D) may be due remnant nanoparticles or residues from the 
synthesis process.  
Raman spectroscopy was performed using a Renishaw micro-Raman 
spectrometer with a 632 nm excitation laser. Raman data were collected under a 50× 
91 
 
long working distance objective at 1.3 mW incident power for HCNT powders on glass 
slides. The Raman spectra (Figure 24) show two distinct peaks at ~1334 and ~1592 
cm-1, commonly referred to as the D and G peaks in carbon nanomaterials. The G peak 
is attributed to the in plane stretching of the sp2 hybridized C-C sigma bond. The D 
peak is attributed to disorder in the crystal structure which breaks translational 
symmetry, allowing for breathing of the carbon hexagons in the lattice [187]. 
Size distribution and zeta potential of the HCNTs was performed using a 
Zetasizer Nano ZS (Red Badge) ZEN3600 (Malvern Instruments, Paris, France) with 
the nanotubes dispersed in the dispersal media. Particle size distribution of dispersed 
samples demonstrated a mean diameter of 532 nm (Figure 25). The zeta potential of 
dispersed HCNTs in dispersal media was determined to be -3.04 mV. 
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II. FIGURES 
 
 
 
 
 
 
 
 
 
Figure 19. A representative SEM of dispersed nanotubes shows moderate variability in 
the diameter of individual tubes as well as sharp kinks and folding. 
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Figure 20. (A- i to iv) Typical SEM images of helical HCNT powder adhered on double 
sided carbon tape, and (A- v and vi) on a SiO2/Si substrate following vacuum filtration 
and transfer from a nitrocellulose membrane. (B) Histogram of HCNT diameter 
distribution obtained from the SEM images of (A), showing an average diameter of ~200 
nm with distribution (dHCNT = 199.9±127.8 nm, n=80) as indicated. 
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Figure 21. (A- i to vi). Typical SEM images used to measure lengths of HCNTs. (B) 
Histogram of HCNT length distribution obtained from the SEM images of (A), showing 
an average length of ~1.9 μm with distribution (LHCNT = 1.9±0.8 μm, n=50) as indicated. 
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Figure 22. EDX analysis of the HCNTs on a Si surface. The EDX reveals the Si 
substrate, C from the helical HCNTs, and trace elements of O and Fe from the transfer 
and growth processes, respectively. Inset: a SEM micrograph of the region under 
assessment by EDX. HCNTs and tape residues are apparent. 
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Figure 23. (A) XPS survey of HCNT Powder. (B) High resolution C 1s XPS spectra 
shows components at 284.5 eV (Helical CNTs) and ~290 (satellite peak for graphitic 
carbon). Scatter points are raw data and solid lines are fits and background. (C) High 
resolution Cl 2p XPS spectra and (D) High resolution Al 2p XPS spectra. 
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Figure 24. Raman spectroscopy data for helical HCNT powder showing peaks related to 
the doubly degenerate optical phonon mode at the Brillouin zone center (G-peak) in 
graphitic materials, and a disorder-induced peak related to defects in the crystal 
structure (D-peak) [187]. 
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Figure 25. Dynamic light scattering of HCNTs dispersed in our media show a mean 
diameter of 532 nm. 
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